Coronary heart disease and cardiac rehabilitation.
Participation rate, predictors and effects on symptoms of anxiety and depression, and employment status of patients following percutaneous coronary intervention - A nationwide prospective cohort study by Olsen, Siv Jorunn Storli
Faculty of Health Sciences 
Coronary heart disease and cardiac rehabilitation 
Participation rate, predictors and effects on symptoms of anxiety and depression, and 
employment status of patients following percutaneous coronary intervention -      
A nationwide prospective cohort study 
Siv J. S. Olsen
A dissertation for the degree of Philosophiae Doctor (PhD) – December 2019 
i 
Table of Contents 
Acknowledgements ................................................................................................................... 1 
List of abbreviations ................................................................................................................. 2 
List of papers ............................................................................................................................ 3 
Summary ................................................................................................................................... 4 
Summary in Norwegian ........................................................................................................... 6 
1 Introduction ...................................................................................................................... 8 
2 Background ....................................................................................................................... 9 
Coronary heart disease ................................................................................................. 9 
Cardiac rehabilitation ................................................................................................ 11 
Anxiety and depression ............................................................................................. 16 
Employment status .................................................................................................... 20 
Aims of the thesis ...................................................................................................... 22 
3 Material and methods .................................................................................................... 23 
Study population - The Norwegian Coronary Stent Trial ......................................... 23 
Data collection ........................................................................................................... 26 
Data management ...................................................................................................... 26 
Study variables .......................................................................................................... 26 
3.4.1 Cardiac rehabilitation (Papers I-III) ................................................................... 27 
3.4.2 The Hospital Anxiety and Depression Scale (Paper II) ..................................... 28 
3.4.3 The Norwegian reference population (Paper II) ................................................ 30 
3.4.4 Employment status (Paper III) ........................................................................... 30 
Statistical analysis...................................................................................................... 31 
3.5.1 Descriptive statistics ........................................................................................... 31 
3.5.2 Comparisons ....................................................................................................... 32 
3.5.3 Regression .......................................................................................................... 32 
ii 
3.5.4 Propensity score ................................................................................................. 32 
Ethics ......................................................................................................................... 33 
3.6.1 Funding ............................................................................................................... 34 
3.6.2 User involvement ............................................................................................... 34 
4 Summary of results ........................................................................................................ 35 
Paper I ........................................................................................................................ 35 
Paper II ...................................................................................................................... 37 
Paper III ..................................................................................................................... 38 
5 Discussion of methodology............................................................................................. 39 
Study design .............................................................................................................. 39 
5.1.1 Statistical conclusion validity ............................................................................. 40 
5.1.2 Internal validity .................................................................................................. 41 
5.1.3 Construct validity ............................................................................................... 44 
5.1.4 External validity ................................................................................................. 44 
6 Discussion of main results.............................................................................................. 45 
Cardiac rehabilitation participation ........................................................................... 45 
Symptoms of anxiety and depression and cardiac rehabilitation .............................. 47 
Employment status and cardiac rehabilitation ........................................................... 49 
7 Conclusions and future perspectives ............................................................................ 51 




List of tables 
Table 1. Inclusion and exclusion criteria for the Norwegian Coronary Stent Trial. p. 27
Table 2. Baseline characteristics of total population and differences between study 
participants and those lost to follow-up. p. 29
Table 3.  Baseline characteristics according to duration of cardiac rehabilitation.  p. 32
Table 4. Description of subscales, internal consistency and missing data without and with 
missing imputation at baseline and three years follow-up. p. 34
Table 5. Categorization of different combinations of the employment status response in the 
entire cohort, and numbers of participants in each category .    p. 35
Table 6.  Odds ratios for participation in cardiac rehabilitation, stratified by regional health 
authorities in Norway.         p. 40
Table 7.  Design used to prove a causal relationship in the present thesis. p. 43
List of figures 
Figure 1. Leading causes of death in Norway 1998-2017. p. 13
Figure 2. Flow diagram demonstrating inclusion and exclusion of participants at baseline and 
at three years follow-up in NorStent.        p. 28 
iv 
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Summary 
Background: Improved medical treatment and therapeutic procedures coupled with an ageing 
population have increased the numbers of people living with coronary heart disease (CHD). 
This chronic condition has implications for patients’ everyday lives, including their physical, 
physiological and social well-being. According to international guidelines, cardiac 
rehabilitation (CR) is an integral component of secondary prevention and a recommended 
form of aftercare for patients with established cardiovascular disease. The key elements of CR 
consist of lifestyle interventions, risk factor management, and physiological and vocational 
support. No national estimates exist on the proportion of patients participating in CR 
programmes in Norway. In addition, the new era of revascularization and advances in 
secondary prevention therapy call for updated knowledge of the impact of CR programmes on 
patients’ mental health and vocational reintegration.  
Aim: The aims of this thesis were to study the CR participation rate, clinically relevant 
anxiety and depression and employment status of patients following percutaneous coronary 
intervention (PCI), and the long-term effect of participation in a CR programme on patients’ 
symptoms of anxiety and depression and their employment status. 
Methods: Using a prospective observational design, we included data from the Norwegian 
Coronary Stent trial (NorStent) from baseline and 36 months in the present thesis. NorStent 
was an all-comer study with broad inclusion criteria and few exclusion criteria, conducted at 
all centres in Norway that perform PCI during 2008 and 2011. A total of 9013 participants 
were included in NorStent. Clinical data at the time of PCI were retrieved from the patients’ 
electronic medical records. Symptoms of anxiety and depression were assessed using the 
Hospital Anxiety and Depression Scale (HADS) in a representative sample of 775 patients at 
baseline. At three years follow-up, 7068 patients (82%) responded to a postal survey that 
included the HADS and questions on CR participation and employment status.  
Results: Twenty-eight per cent of the participants reported having participated in a CR 
programme. The participation rate differed among the four regional health authorities in 
Norway (20%-31%). A multivariate statistical model revealed that men had a 28% lower 
probability of participating in CR, and the likelihood of attending CR decreased with 




undergone PCI for an acute coronary syndrome, educational level >12 years, and overweight. 
Prior coronary artery bypass graft was associated with lower CR participation. CR 
participants had higher levels of symptoms of anxiety and depression than non-participants at 
baseline, and both groups had higher levels than the general population. The levels of anxiety 
and depression had fallen significantly at three years follow-up. In the propensity-matched 
cohort, CR participants had more clinically relevant symptoms of anxiety, but not depression. 
Female gender and younger age were associated with higher probability of clinically relevant 
symptoms of anxiety, whereas older age, lower levels of education and cardiovascular 
morbidity were associated with higher probability of clinically relevant symptoms of 
depression. Seventy per cent of participants who were <60 years of age at the index event 
were employed at three-year follow-up. In the propensity-matched cohort, employment status 
did not differ between CR participants and non-participants. Being male, living with a 
partner, and attaining higher levels of education were associated with a higher chance of 
being employed, while being older, prior cardiovascular morbidity, and former smoking were 
associated with a lower chance of being employed three years after PCI. 
Conclusion: This thesis suggests that few patients with established CHD participate in a CR 
programme, with certain geographical differences. A significant number of patients who have 
undergone PCI report symptoms of anxiety and depression, with the highest levels found in 
those participating in a CR programme. After three years, both the CR participants and non-
participants had a higher level of anxiety, but not depression, than the general Norwegian 
population. A significant number of working-age CHD patients were unemployed three years 
after PCI and CR appeared to have no beneficial effect on clinically relevant symptoms of 
anxiety and depression or employment status. The present thesis suggest that the patients 
most in need, i.e. those who are overweight, smokers, and have the highest levels of anxiety 





Summary in Norwegian 
Bakgrunn: Antallet som lever med hjerte- og kar sykdommer øker på grunn av bedre 
medikamentell- og invasiv behandling. Å leve med kronisk hjertesykdom påvirker pasientens 
hverdag og den fysiske, fysiologiske og sosiale velvære. I henhold til internasjonale 
retningslinjer er hjerterehabilitering en integrert del av den sekundærforebyggende 
behandlingen og anbefalt i oppfølgingen av pasienter med etablert hjerte- og karsykdom. De 
sentrale elementene i hjerterehabilitering består av optimalisering av livsstilsfaktorer, 
kartlegging av risikofaktorer, fysisk trening og arbeidsveiledning. I dag finnes det ikke 
nasjonale data på andelen pasienter som deltar på hjerterehabilitering i Norge. I tillegg krever 
de nye fremskrittene innen invasiv behandling og sekundærforebygging, oppdatert kunnskap 
om effekten av hjerterehabilitering på pasienters mentale helse og integrering i arbeidslivet. 
Hensikt: Hensikten med denne avhandlingen var å estimere omfanget av deltagelse på 
hjerterehabilitering, klinisk relevant angst og depresjon og ansettelsesstatus hos pasienter som 
har gjennomgått perkutan koronar intervensjon (PCI), og den langsiktige effekten av 
deltakelse på hjerterehabilitering på pasientens symptomer på angst og depresjon og 
ansettelsesstatus. 
Metoder: Ved bruk av et prospektiv observasjonelt design brukte vi i denne avhandlingen 
baseline og 36 måneder data fra Norwegian Coronary Stent-studien (NorStent). NorStent var 
en studie med få restriksjoner for inklusjon og ble utført i tidsrommet 2008 til 2011 ved alle 
sentre i Norge som utførte PCI. Totalt ble 9 013 deltakere inkludert i NorStent. Kliniske data 
på tidspunktet for PCI ble hentet fra den elektroniske pasient journalen. Symptomer på angst 
og depresjon ble kartlagt ved bruk av Hospital Anxiety and Depression Scale (HADS) i et 
representativ utvalg på 775 pasienter ved baseline. Etter tre års oppfølging svarte 7 068 
pasienter (82%) på et spørreskjema som inkluderte HADS og spørsmål om deltakelse på 
hjerterehabilitering og ansettelsesstatus. 
Resultater: Tjueåtte prosent av studiedeltakerne rapporterte å ha deltatt på et 
hjerterehabiliterings program. Deltakelsesgraden var forskjellig mellom de fire regionale 
helseforetakene i Norge (20%-31%). En multivariat statistisk modell avdekket at menn hadde 
28% lavere sannsynlighet for å delta på hjerterehabilitering, og oddsen for å delta ble lavere 
med økende alder. Faktorene for høyere odds for deltakelse på hjerterehabilitering var 
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pasienter som gjennomgikk PCI på grunn av akutt koronart syndrom, utdanning mer enn 12 år 
og overvekt. Tidligere koronar bypassoperasjon var assosiert med lavere odds for deltagelse 
på hjerterehabilitering. De som deltok på hjerterehabilitering rapporterte høyere nivåer av 
symptomer på angst og depresjon enn de som ikke deltok ved inklusjon, og begge gruppene 
rapporterte høyere nivåer enn den generelle befolkningen. Nivået av angst og depresjon falt 
betydelig i løpet av tre års oppfølging. I den propensity-matchede kohorten var det flere med 
klinisk relevante symptomer på angst, men ikke depresjon, hos de som hadde deltatt på 
hjerterehabilitering. Kvinner og yngre hadde større sannsynlighet for klinisk relevante 
symptomer på angst, mens eldre, de med lavere utdannelsesnivå og de med tidligere hjerte- og 
karsykdom hadde høyere sannsynlighet for klinisk relevante symptomer på depresjon. Sytti 
prosent av deltakerne som var <60 år ved inklusjon var i arbeid etter 3 år. I den propensity-
matchede kohorten skilte ikke ansettelsesstatusen til de som hadde deltatt på 
hjerterehabilitering seg fra de som ikke hadde deltatt. Menn, samboende og de med høyere 
utdanningsnivå hadde større sannsynlighet for å være i arbeid, mens eldre, de med tidligere 
hjerte- og karsykdom og de som hadde tidligere røykt hadde lavere sannsynlighet for å være i 
arbeid tre år etter PCI. 
Konklusjon: Funnene i avhandlingen indikerer at få pasienter med etablert hjertesykdom 
deltar på et hjerterehabiliteringsprogram, og at det er visse geografiske forskjeller i andel 
deltagelse. Et betydelig antall pasienter som gjennomgår PCI rapporterer symptomer på angst 
og depresjon, og de med høyest nivå deltar på hjerterehabilitering. Etter tre år hadde både 
hjerterehabiliterings deltakerne og de som ikke deltok et høyere angstnivå, men ikke 
depresjonsnivå, sammenlignet med resultater fra den generelle norske befolkningen. Et 
betydelig antall hjertepasienter i arbeidsfør alder var arbeidsledige og hjerterehabilitering 
syntes ikke å ha gunstig effekt på klinisk relevante symptomer på angst og depresjon eller 
ansettelsesstatus tre år etter PCI. Denne avhandlingen indikerer at pasientene som har særlig 
behov, overvektige, røykere og pasienter med mest symptomer på angst og depresjon, 
identifiseres og oppfordres til å delta på hjerterehabilitering.  
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1 Introduction 
One-fifth of the Norwegian population are living with cardiovascular disease; every year, 
about 40 000 coronary heart disease (CHD) patients have an outpatient consultation or 
hospital admission. Improved medical treatment and therapeutic procedures coupled with an 
ageing population have increased the numbers of people living with CHD in Norway (1). This 
chronic condition has implications for patients’ everyday lives, including physical, 
physiological and social wellbeing. Patients diagnosed with CHD, especially those that have 
experienced a life-threatening event, are in a situation where they try to accept the potential 
consequences the disease has on their daily life and future. Mental health and social and 
vocational reintegration are therefore of importance, and patient-reported outcomes can 
complement the understanding of the burden of the disease. 
According to international guidelines, cardiac rehabilitation (CR) should be a core component 
of the care received by patients with established CHD (2-4). The key elements of CR consist 
of lifestyle interventions, risk factor management, and physiological and vocational support 
(5). Studies have shown great variation in the content of CR programmes and participation 
rates across Europe and worldwide (6-9). In Norway, there are no uniform national standards 
and guidelines for CR, and there is a lack of knowledge of participation rates. 
The aim of this thesis is to enhance understanding of CR. Specifically, we wanted to study the 
CR participation rate, clinically relevant anxiety and depression and employment status in 
patients having undergone percutaneous coronary intervention (PCI), and the long-term effect 
of participation in a CR programme on patients’ mental health and vocational reintegration.  
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2 Background 
Coronary heart disease 
Cardiovascular disease (CVD), in addition to stroke, has remained the top cause of death 
worldwide in the last 15 years, and resulted in the death of 15 million people in 2015 (10). In 
Europe, more than 4 million people die from CVD every year and CVD accounts for 45% of 
all deaths. There is also substantial variance in the CVD burden across Europe between high- 
and low-income countries (11). Despite a decrease in mortality over the last fifty years, CVD 
is still the most common cause of death in Norway along with cancer (Figure 1) (1, 12). In 
2017, there were 20 704 hospitalizations for myocardial infarction (MI), representing 12 087 
unique persons, according to the Norwegian Myocardial Infarction Register (13). Of these, 
30% have had one or more previous MIs, and this figure has remained stable for the last five 
years (13).  
Figure 1. Leading causes of death in Norway 1998-2017 (12) 
Development of coronary heart disease 
The development of atherosclerosis starts in early life, indicating that CHD develops over the 
life course (14). The atherosclerotic process is well understood. Studies suggest that 
atherosclerosis represents a maladaptive chronic vascular immune-inflammatory disease of 
the medium-sized and large arteries (15). Inside the artery, there is a thin layer of cells, the 
endothelium. When the endothelium is damaged, monocytes attach to the surface and 
transmigrate into the sub-intimal space where they transform into macrophages. The 
macrophages attract and consume fatty low-density lipoproteins (LDL), and turn into large 
foam cells that cause arterial inflammation when they collapse. The combination of modified 
LDL particles, macrophages, lymphocytes, and dendritic cells that release several pro-
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inflammatory factors such as cytokines and chemokines, describes the atherosclerotic plaque 
(15, 16). A plaque-affected obstruction of the coronary artery or spasm of normal or plaque-
diseased arteries is generally typical of stabile angina (17). 
Vulnerable plaques are defined as those with a significant level of inflammation and a thin 
fibrous collagen cap that is prone to rupture with increased risk of thrombosis. A ruptured 
plaque is an atherosclerotic vascular lesion with damage that exposes the thrombogenic core 
of the plaque (16, 18). A ruptured or eroded arteriosclerotic coronary plaque followed by 
thrombus formation and propagation are the essential elements in the pathophysiology of 
acute coronary syndrome. Acute coronary syndrome includes unstable angina, non-ST-
segment elevation infarction and ST-segment elevation infarction (18).  
Risk factors for coronary heart disease  
In contrast to a bacterial infection, CVD has no single cause. This makes it possible to 
develop CVD without the influence of some of the major known risk factors. The presence of 
co-existing risk factors makes it challenging to explore the direct causal effect because of the 
high risk of bias. However, international guidelines highlight several factors that can promote 
CVD (19), which are the same factors used in risk assessment systems to estimate the future 
risk of fatal CVD (20, 21). In the 1960s, the Framingham study addressed smoking, and 
raised blood pressure, serum cholesterol and diabetes mellitus as risk factors for CVD (22). 
Today, obesity, physical inactivity, dietary patterns and alcohol have been added as 
modifiable risk factors for CVD (23, 24).  
Smokers have a tripled risk of non-fatal MI (25), and patients that cease smoking lower their 
risk of recurrent MI by 43% (26). In addition, second-hand smoke and occasional smoking 
increase mortality (27, 28). A reduction of one mmol/L in total cholesterol is associated with 
a reduction in CHD mortality of about 50% in people aged 40-49 years and 17% in those aged 
70-79 (29). High diastolic and systolic blood pressure are both associated with increased risk
of CVD, and antihypertension treatment reduces CHD mortality by 10-12% (23). Obesity,
both in adolescence and adulthood, increases the risk of CVD (30). A body mass index (BMI,
kg/m) of 30-35 reduces median survival by 2-4 years and with a BMI of 40-45 the median
lifespan is reduced by 8-10 years, comparable with the effect of smoking (31). Observational
long-term studies have shown a significant relationship between leisure time activity and
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reduced all-cause and cardiovascular mortality (23, 32). Even small doses of physical activity 
decrease mortality, with the highest effect in the least fit patients (33). Recommended diet and 
exercise adherence are associated with a decreased risk of MI of almost 50% compared to 
non-adherence (26).  
A meta-analysis of 20 studies found a 28% increased risk of CHD with the presence of 
anxiety in initially healthy individuals (34). The INTERHEART study comparing 15 152 
cases and 14 820 controls found that psychosocial factors, such as depression, anxiety and job 
stress, increased the risk of MI by 2.67 (24). An additional publication from the 
INTERHEART study revealed that severe global stress increased the risk of acute MI less 
than smoking, but comparable to hypertension and obesity (35). A Norwegian population-
based study showed that symptoms of anxiety and depression increased the risk of future 
acute MI by 25% and 31%, respectively (36). In addition to the modifiable risk factors, CVD 
risk is affected by age, gender and genetic factors (19). 
Percutaneous coronary intervention (PCI) 
Minimization of residual ischaemia is the goal of revascularization and gives a future benefit 
of decreased risk of death and myocardial infarction (37). An invasive strategy is the standard 
of care in patients with suspected coronary heart disease to confirm the diagnosis, identify the 
culprit lesion, establish the indication for coronary revascularization and stratify the patient’s 
risk (4). In 1977, Andreas Gründzig performed the first PCI with balloon dilatation of the left 
coronary artery. A high rate of acute closure and restenosis of the treated artery resulted in the 
introduction of coronary stents (38). Today, pre-dilation followed by implantation of a stent is 
the established PCI procedure in both acute and elective patients with a significant stenosis in 
the coronary artery. In 2017, 32 101 invasive procedures were performed in Norway, 41% of 
which included PCI. Approximately half of the procedures were in relation to an acute 
coronary event (39). 
Cardiac rehabilitation 
In CHD patients, secondary prevention is recommended with the aim of slowing down the 
progression of the disease and improving the chance of positive health outcomes. Secondary 
prevention and cardiac rehabilitation are integral components in the comprehensive care of 
patients with established CHD (5, 40).  
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History of cardiac rehabilitation 
Until the 1950s, strict bed rest was the recommended care after acute MI followed by gradual 
gentle mobilization. Patients who had an MI were often considered invalid and many were 
forced into early retirement. Levine and Lowe introduced ‘The chair treatment after an acute 
MI’, where patients were mobilized to an armchair, and the term CR was introduced to the 
literature (41). In the late 1950s, Dr Hellerstein introduced one of the first multidisciplinary 
approaches to disease with a clinic staffed by physiotherapists, dietitians, vocational 
counsellors, and psychotherapists. Exercise, diet, and return to work were the main goals in 
the post-infarct care model (42). During the 1980s, randomized controlled trials (RCTs) 
showed that structured CR reduced mortality and morbidity and was cost-effective. However, 
the intensive exercise programme did not show long-term effects, probably because of non-
adherence. These findings resulted in more moderate exercise training, which is the basis for 
current practice in CR in several countries (41-43).  
Components of cardiac rehabilitation 
The World Health Organization has developed the most quoted definition of CR (44): 
‘The sum of activity required to ensure cardiac patients the best possible 
physical, mental and social conditions so that they may, by their own effort, 
regain as normal as possible a place in the community and lead an active life’ 
International consensus (guidelines and textbooks) recommends that the core components of 
today’s CR should include lifestyle interventions, risk factor management, and psychosocial 
and vocational support. The short-term goals for CR are to manage cardiac symptoms, 
improve functional capacity, limit psychological distress, and give vocational support to the 
patient. This includes providing education about the condition, optimizing medical treatment 
and management of blood pressure, cholesterol and blood glucose, and reduction of 
psychosocial distress and barriers for returning to work (3). The long-term goal is to stabilize 
or slow the progression of arteriosclerosis, thereby reducing morbidity and mortality, and 
minimizing the risk of future cardiac events (5, 45, 46). This includes motivating patients to 
long-term lifestyle changes such as smoking cessation and healthy dietary habits, and 
promoting medical adherence, physical activity and weight management (3). Several 
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international guidelines recommend CR as a core component of care for patients with 
established coronary heart disease (3, 4, 47). 
CR programmes are divided into three phases. Phase 1 starts at the hospital immediately after 
the coronary event. The goal is to promote early mobilization and prevention of 
complications. Phase 2 can be performed in both inpatient and outpatient settings; here, the 
aims are clinical stabilization, risk stratification, and the promotion of a long-term healthy 
lifestyle. Phase 3 is a long-term outpatient CR programme provided in outpatient settings and 
focusing on physical activity (23). 
Over the years, different theoretical perspectives have guided CR, depending on the elements 
emphasized. The social cognitive theory, introduced by Albert Bandura, has been used to 
promote lifestyle changes. Self-efficacy is an important aspect of the social cognitive theory, 
representing the person’s belief in her or his ability to succeed in specific situations or 
accomplish a task (48). Prochaska and DiClemente’s transtheoretical, or stages of change, 
model describes several stages involved in the process of health behaviour change (49). 
Coping with illness is also a component of CR, theorized by Lazarus and Folkman (50) and 
Miller (51), as coping can affect mental and physical health. The salutogenic theory of 
Antonovsky highlights health promotive factors, as opposed to treating illness, and has a 
component of coping strategies known as the sense of coherence (52, 53).  
Today, CR programmes have added theories that emphasize person-centred care. 
Empowerment focuses on strengthening individuals to allow them to recognize and use their 
resources and represent their interests in a responsible and self-determined way (54). 
Motivational interviewing seeks to increase the individual’s motivation for change (55). 
Health literacy is the degree to which a person can access, practice, and understand basic 
health information and services in order to inform and participate in health decisions (56). 
Health literacy is an invisible barrier to healthcare delivery, and limited health literacy is 
associated with poorer health care and overall health status, increased hospitalizations, and 
decreased adherence to medications (57, 58). Limited health literacy is more often present 
among older adults, ethnic minorities, individuals with chronic illness and individuals with 
low education (57, 58). There is a limited number of studies exploring health literacy among 
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patients with CHD, but it is suggested that health literacy plays an important part in aftercare 
for patients with established CHD (57). 
Effects of cardiac rehabilitation 
A Cochrane systematic review and meta-analysis published in 2011 including 47 studies with 
10 794 CHD patients showed that exercise-based CR was associated with a reduction in all-
cause mortality (RR 0.87, 95%  CI 0.75-0.99), cardiovascular mortality (RR 0.74, 95% CI 
0.63-0.87) and hospital admissions (RR 0.69, 95% CI 0.51-0.93), but not total MI and 
revascularization (59). The updated version of this review from 2016 concluded with similar 
findings, but no reduction in all-cause mortality. In addition, the authors identified evidence 
supporting improved health-related quality of life (HQoL), but failed to conduct the meta-
analysis needed to establish robust conclusions (60). Notably, a benefit in all-cause mortality 
was found by Rausch et al., who included both RCTs and prospective cohort studies (61).  
Since reviews and meta-analyses including studies before the new era of revascularization and 
advances in secondary prevention therapy may have overestimated the effect of exercise-
based CR, Powell et al. performed a systematic review and meta-analysis of only studies 
including patients after the year 2000 (62). Including 22 studies with 4834 participants,  
Powell et al. did not find any effect of exercise-based CR on all-cause mortality or 
cardiovascular mortality, but a small reduction in hospital admission that were unlikely to be 
of clinical significance (62). In patients with stable angina, the effect of exercise-based CR on 
all-cause mortality, cardiovascular mortality, MI and cardiovascular hospital admissions is 
uncertain due to few studies with low quality (63). 
Halewijn et al. included not only exercise-based CR but also lifestyle-based programmes in 
their review and meta-analysis of studies published in 2010-2015 (64). When adding 
rehabilitation programmes addressing six or more risk factors or prescribing and monitoring 
of cardioprotective medication, they found a reduction in all-cause mortality, cardiovascular 
mortality, MI and cerebrovascular events (64). The comprehensive approach has also been 
shown to be beneficial by Kabboul et al. (65). There is no strong evidence that patient 
education alone reduces all-cause mortality, cardiac mortality, revascularization or 
hospitalizations (66), but attending a group-based educational intervention is associated with 
almost halved all-cause and cardiovascular mortality after first-time MI (67). Exploring the 
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effect of CR on HQoL, two recent meta-analyses support the findings of Shepherd and While 
that CR may lead to a clinically meaningful improvement in HQoL (68-70). Evidence also 
suggests that CR is cost-effective (71, 72).  
Several of the previously mentioned meta-analyses report that the included studies come from 
a wide variety of clinical environments, and that the CR intervention ranged greatly in quality, 
as also noted by the European cardiac rehabilitation registry (73). Caution is therefore advised 
when reading the findings. However, a systematic review of recent CR meta-analyses 
concludes that the results are sufficiently robust in favour of CR that strategies to improve 
referral rates should be promoted (74).   
Participation rate 
Participation in CR programmes after an acute coronary event varies widely across Europe, 
from 0% to 91% (6, 9, 75). Barriers to participation can be categorized as patient-related, 
provider-related and system-related barriers (76). Patient-related barriers are lack of 
awareness and perceived need, lack of social support, poor physical wellbeing, living at a 
distance from the CR, competing work commitments and financial costs. Provider-related 
barriers are lack of knowledge of the benefits of CR, lack of knowledge on how to refer, the 
site location or perceptions that patients lack motivation to participate in CR. System-related 
barriers are capacity constraints, lack of reimbursement by the government and lack of 
national standards (5, 76-78). The typical non-participant is an older woman, living at some 
distance from the nearest CR, with a low educational level, living alone and having 
comorbidities (79). There is a lack of knowledge on interventions to promote CR adherence, 
but interventions targeting patient-related barriers may increase the possibility of success (9). 
Cardiac rehabilitation in Norway 
Several studies have found poor risk factor control in patients with established CHD in 
Norway (80-83). Today, there is a lack of uniform national standards and guidelines for CR 
and no national secondary prevention register. A report from 2018 on rehabilitation in 
specialist health services in Norway showed a reduction in numbers of patients receiving 
rehabilitation and wide geographical differences in the use of rehabilitation (84).  
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There is also great variation in the duration and content of the different CR programmes in 
Norway. Some hospitals offer a one- to three-day course with a focus on educational 
programmes to increase knowledge of the disease and coping skills (the ‘Heart School’). 
Others have an outpatient programme, focusing solely on exercise training or with a 
comprehensive approach lasting for 2-6 months. The National Association for Heart and Lung 
Disease (LHL), a wholly patient-owned non-profit organization, offers in-hospital 
comprehensive CR over four weeks. Different private CR centres offer in-hospital or 
outpatient CR programmes lasting for three to four weeks. Finally, municipalities with 
Healthy Life Centres offer exercise training and different courses to optimize a healthy 
lifestyle, such as smoking cessation. Unpublished data from a national survey conducted by 
Sverre and Peersen showed that 85% of Norwegian hospitals have a systematic referral to CR 
for MI patients, 24% offer an outpatient follow-up consultation, 22% offer comprehensive 
CR, 45% offer ‘Heart School’ and outpatient exercise training, 24% offer ‘Heart School’ only 
and 10% have no CR programme to offer (85). As in Norway, Sweden has variation in length 
and content of CR between hospitals (86). However, Sweden has systematic follow-up of 
acute MI patients monitored by the SWEDEHEART registry for quality control and 
improvement (86). 
In Norway, those offered CR are primarily MI patients. A study comparing CR in two 
neighbouring hospitals in Norway revealed a large difference in participation rates (75% vs. 
18%) (87). In the future, the Norwegian Myocardial Infarction Register will publish data on 
CR participation rates.  
Anxiety and depression 
Definition and prevalence 
Occasional anxiety is an expected part of life and is an emotion that occurs when an 
individual faces potentially harmful or worrying triggers. Anxiety increases psychological 
activity of the body such as rapid heart rate and increased blood pressure. People with anxiety 
disorders have recurring intrusive thoughts or concerns and typically avoid certain situations 
out of worry (88, 89). Depression generally involves symptoms such as a feeling of depressed 
mood, a loss of interest or pleasure in activities, sleep disturbance, fatigue, or impaired 
concentration. Symptoms must last at least two weeks for establishing a diagnosis of 
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depression (89-92). Depending on the number and severity of symptoms, a depressive episode 
can be categorized as mild, moderate or severe (89-93). 
Anxiety and depression are common during a lifetime. Epidemiological studies, using the 
Diagnostic and Statistical Manual of Mental Disorders (90), have showed a lifetime 
prevalence of anxiety- and depressive disorders of 14%-50% and 14%-21%, respectively 
(94). Notably, comorbidity between anxiety and depression is strong, and as many as 40%-
50% have both conditions (95). 
Aetiology 
Several idioms describe the connection between the heart and emotion, such as heartbroken, 
cold-hearted, heartless and stony-hearted. As early as in the 1930s, clinical scientists 
documented an association between late-life depression and elevated rates of cardiovascular 
deaths (96). The link between mental illness and CHD is not fully understood, but there is a 
consensus among scientists that the association is driven through pathways of biological and 
behavioural mechanisms with bidirectional influences (97-100). The biological mechanism is 
explained by an autonomic nervous dysfunction with a reduction in catecholamine spillover, 
pre-ejection period, heart rate variability, baroreflex sensitivity, heart rate recovery after 
exercise and an increased heart rate. In addition, there is a dysfunction in the hypothalamic-
pituitary adrenal axis influencing the levels of cortisol leading to increased free fatty acids. 
There is also an endothelial dysfunction, higher levels of fibrinogen and other clotting factors 
and elevated inflammatory biomarkers. Overall, these factors contribute to more rapid 
progression of atherosclerosis, higher risk of vulnerable plaque and higher risk of 
atherothrombosis (97-103). Psychological factors are associated with adverse lifestyle 
behaviours related to smoking, physical activity, diet, alcohol consumption and sleep health. 
Patients with mental illness are also less likely to adhere to medication, lifestyle changes and 
cardiac rehabilitation (93, 97-99, 104). 
Prevalence of anxiety and depression in CHD patients 
The prevalence of anxiety among CHD patients is reported to be 13%-60% (104-107), while 
of whom only 15-20% meet the criteria for major depression, while the rest are suggested to 
have clinically relevant depression (93, 104, 108). Several factors can contribute to the 
differences in prevalence. Changes over time in the detection, prevention and treatment of 
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CHD complicate the interpretation of this literature. Furthermore, the studies are 
characterized by several methodological differences, such as differences in instruments 
measuring symptoms of anxiety and depression, categorical variables versus continuous 
scores, time from index event to assessment, repeated measuring and differences in cut-off 
score. Studies have shown that symptoms of anxiety in CHD patients were more prevalent in 
women, younger patients and patients with a low education level (104, 109). Old age, low 
level of education and presence of smoking, obesity and diabetes were more prevalent in 
CHD patients with symptoms of depression (104, 109). 
Anxiety and depression and cardiac outcomes 
Meta-analyses suggest that anxiety is associated with a slightly increased risk of mortality and 
poor cardiac outcomes in patients with CHD (106, 110). A systematic review found an 
increased risk of major adverse cardiac events in patients with general anxiety disorder (107). 
The association between anxiety and cardiac outcomes seems less strong than it is for 
depression. A systematic review of 54 studies by Lichtman et al. concluded that comorbid 
depression increases the risk of all-cause mortality, cardiac mortality, and composite 
outcomes comprising mortality and nonfatal cardiac events (108). In a PCI population, 
symptoms of depression were associated with an almost two-fold greater risk of mortality at 
10 years follow-up, and symptoms of anxiety were associated with a 50% higher risk of 10-
year mortality (111). However, anxiety disappears as a predictor of mortality when adjusting 
for depression (111). 
Effect of cardiac rehabilitation on anxiety and depression 
Exercise-based CR has been shown to reduce anxiety (112) and depression (112, 113) and 
psychological support as stress management, relaxing techniques or individual counselling, is 
thus recommended as a component of CR (91, 102, 114). However, the scientific evidence for 
this recommendation was challenged by a Cochrane review that did not find any effect on 
total mortality, need for revascularization, or the risk of non-fatal myocardial infarction of 
adding psychological interventions to traditional CR (115). However, cardiac mortality was 
reduced, and symptoms of anxiety, depression and stress were improved (115). A recent 
review and meta-analysis including randomized controlled trials and controlled cohort trials 
published between 1995 and 2017 found similar findings to the Cochrane review with regard 
to the effect on cardiovascular events, revascularization procedures and risk reduction for 
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non-fatal MI (116). The findings also suggested that specific psychological interventions may 
reduce depressive symptoms, but they had no effect on anxiety and quality of life (116). 
Furthermore, no effects of antidepressant treatment on cardiac outcomes have been observed 
(117). Notably, reviews on the effectiveness of psychological interventions have been 
criticized for including studies of moderate to low quality and with heterogeneity in terms of 
interventions, outcomes and follow-up period (118). The findings should therefore be 
interpreted with caution. Nevertheless, international guidelines emphasize that CR is a 
multicomponent intervention that includes screening for anxiety and depression and giving 
psychological support to those in need (19, 46).  
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Employment status 
Remaining in the workforce despite having a chronic disease holds important socioeconomic 
consequences for the patient and society. There is strong evidence of the protective effect of 
employment, especially on depression and general mental health (107). Today, 79% of 
Norwegians aged 25 to 66 years are employed, while 10% of those aged 18 to 67 receive a 
disability pension, about 5% because of cardiovascular diseases (119). In the 1950s, 
numerous CHD patients failed to return to work after weeks of immobilization. CR started as 
an initiative to improve the chances for returning to work after MI (41, 43).  
Employment status in CHD patients 
The heterogeneity of prior studies on employment status and CHD, such as differences in 
severity of the coronary disease, definition of return to work, state of employment at inclusion 
and follow-up time complicate the interpretation of this literature. In previous international 
studies of employed patients, 76%-93% of the patients were found to have returned to work 
one year after acute MI or coronary artery bypass graft surgery (CABG) (120-124). However, 
subsequent detachment from employment is common; almost a quarter of MI patients of 
working age were detached from employment and received social benefit one year after they 
successfully returned to work (121). A population-based Danish study of 21 926 patients 
showed that five years after first-time hospitalization for acute coronary syndrome, 88% were 
still part of the workforce, and of these, 65% were in work, 19% were unemployed and 16% 
were on sick leave (125). Warraich et al. found that half of the job losses after MI were 
involuntary and patients who experienced an unfavourable change in employment status 
reported decreased quality of life, increased depression and less financial means to buy 
medications (126).  
With regard to early retirement, a nationwide cohort study from Sweden found that 
approximately one-third of patients were granted a disability pension within five years after 
CABG or PCI (127). The reasons for work disability also seemed to change from 
musculoskeletal disorders and mental disorders before an ischaemic heart disease event to 
diseases of the circulatory system after such an event (128). A history of long-term sickness 
absence prior to revascularization is a strong predictor of long-term sickness absence 
following PCI, followed by disability pension (127, 129). In addition, disability pension at the 
time of coronary revascularization is associated with higher five-year mortality (130). 
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Predictors for employment after a coronary event 
Previous studies suggest that younger CHD patients have a higher chance of returning to 
work (121, 123-125, 131), and the EUROASPIRE IV survey revealed that CHD patients 
younger than 50 years old were three times more likely to be employed (124). Some studies 
have shown that women are less likely to return to work (121, 123, 125, 131), while others 
found no gender differences (120, 124). There seems to be a beneficial association between 
being employed and higher educational level, higher socioeconomic status and living with a 
partner (120, 121, 124, 125, 131). Barriers to employment are higher rates of symptoms of 
depression (121, 124), having a manual job (124) and the presence of comorbidities (120, 
121, 124, 125). 
Effect of cardiac rehabilitation on employment status 
The Secondary Prevention and Rehabilitation Section of the European Association of 
Preventive Cardiology (EAPC) suggests dividing actions that lead to successful return to 
work after acute treatment for CHD into human and work-related parameters. These 
parameters should depend on cardiac-related, psychosocial and work-related factors to 
determine the employability of the patient (132), such as assessment of medical 
contraindications, capacity building and re-training (114). However, the benefit of CR on 
employment status is unclear. A Cochrane review that examined interventions to support 
return to work for people with CHD concluded, with low certainty of evidence, that 
comprehensive CR may promote return to work within the first six months following CHD. 
There was little to no evidence that CR promotes return to work between six and twelve 
months after a CHD event, and no evidence that CR promotes return to work after one year of 
follow-up (133). These findings concur with recent studies showing no association of CR or 
psychosocial and vocational interventions with return to work (124, 134). In a survey of CR 
programmes worldwide, more consistent delivery of return to work counselling was promoted 
(8).  
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Aims of the thesis 
The overall aim of this thesis is to provide updated knowledge on aftercare for patients with 
established CHD. Specifically, we wanted to study the prevalence of CR participation, 
clinically relevant anxiety and depression and employment status, and the long-term effects of 
participation in a CR programme on patients’ mental health and vocational reintegration. In 
order to fulfil the overall aim, three different studies were planned:  
I. To determine the approximate proportion of Norwegian CHD patients
participating in CR programmes after PCI, and to determine predictors of CR
participation.
II. To compare levels of anxiety and depression among patients who did and did not
participate in a CR programme after PCI, to compare the findings with the levels
in the general population, and to assess predictors of clinically relevant anxiety
and depression three years after PCI.
III. To determine employment status three years after PCI, compare differences
between CR participants and non-participants, and assess predictors of
employment.
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3 Material and methods 
Study population - The Norwegian Coronary Stent Trial 
The Norwegian Coronary Stent Trial (NorStent) was an all-comer study with broad inclusion 
criteria and few exclusion criteria which was conducted at all centres in Norway that perform 
PCI, thus covering the total Norwegian population of more than 5 million inhabitants (Table 
1). NorStent was a randomized controlled trial comparing long-term health effects of drug-
eluting and bare-metal stents. Participants were included from September 2008 to February 
2011 with five years follow-up.  
Table 1. Inclusion and exclusion criteria for the Norwegian Coronary Stent Trial (135). 
The inclusion criteria were: 
1. Men and women >18 years of age with stable angina pectoris or acute coronary syndrome.
2. The patient has consented to participate and has signed the patient informed consent form.
3. All lesions requiring interventions in one or more native coronary arteries/coronary artery by-
pass graft are amendable for implantation of drug-eluting stents only or bare-metal stents only.
4. The patient has a Norwegian ID number, is able to communicate in Norwegian, and is not
expected to emigrate during study follow-up.
The exclusion criteria were: 
1. Previous implantation of bare-metal or drug-eluting coronary stent(s).
2. Planned intervention for a bifurcation lesion with 2-stent technique.
3. The patient has a serious medical condition (other than coronary artery disease) with a life
expectancy of less than 5 years (such as very severe chronic airway disease or cancer).
4. The patient is currently participating in another randomized trial that clinically interferes with
the present trial, or requires angiography or other coronary artery imaging procedures. 
5. Patients with hypersensitivity or allergy to one of the drugs or components in use with PCI.
6. Contraindications for treatment with clopidogrel/ticlid for 9-12 months.
7. Long-term warfarin use.
A total of 9014 participants were included in the study (Figure 2) (135). Baseline 
characteristics are shown in Table 2. Using a prospective observational design, we included 
NorStent data from baseline and 36 months in the present thesis.  
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Figure 2. Flow diagram demonstrating inclusion and exclusion of participants at baseline and at three 
years follow-up in NorStent 
Papers I and II were based on the 7068 participants with complete status on CR participation 
at three years follow-up. In addition, Paper II was based on data from a representative 
subgroup of 775 participants with complete status on CR and self-reported symptoms of 
anxiety and depression at baseline and at three years follow-up. Paper III was based on the 
2488 participants younger than 60 years at baseline with complete status on CR participation 
and employment status at three years follow-up. Table 2 shows baseline characteristics of 
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participants with complete data at three years follow-up with comparisons to baseline 
characteristics of the 1945 participants lost to follow-up.  
Table 2. Baseline characteristics of total population and differences between study participants and those 
lost to follow-up 
Characteristic  (n=9013) (n=7068) (n=1945) p-value
Age  (years ± SD) 63 ± 10.9 63.1 ± 10.2 60.8 ± 12.9 <0.001 
Male gender, n (%) 6757 (75.0) 5321 (75.3) 1436 (73.8) 0.194 
Living alone, n (%) 1557 (21.1) 1406 (20.8) 151 (25.1) 0.015 
Educational level ≤12 years, 
n (%) 
5575 (69.9) 4683 (68.9) 892 (75.4) <0.001 
Current smoker, n (%) 3147 (34.9) 2226 (31.5) 921 (47.4) <0.001 
Body mass index >25 kg/m2, 
n (%) 
5067 (64.9) 3979 (64.9) 1088 (64.8) 0.272 
Medical history, n (%) 
Prior myocardial 
infarction 
912 (10.1) 664 (9.4) 248 (12.8) <0.001 
Diabetes mellitus 1123 (12.5) 801 (11.3) 322 (16.6) <0.001 
Prior CABG surgery 593 (6.6) 443 (6.3) 150 (7.7) 0.026 
Prior stroke 346 (3.8) 260 (3.7) 86 (4.4) 0.320 
Prior lipid-lowering 
treatment 
4868 (54.0) 3872 (54.8) 996 (51.2) 0.018 
Prior HT treatment 3791 (42.1) 3003 (42.5) 788 (40.5) 0.295 
Left ventricular EF ≤40%, 
n (%) 
303 (8.4) 194 (6.9%) 109 (13.9) <0.001 
Indication for PCI, n (%) 
Stable angina 2636 (29.4) 2124 (30.2) 512 (26.5) 0.012 
Acute coronary 
syndrome 
6319 (70.6) 4901 (69.8) 1418 (73.5) - 
Values are means (SD) or n (%). 
SD: standard deviation; CR: cardiac rehabilitation; CABG: coronary artery bypass graft; HT: hypertension; PCI: percutaneous coronary 
intervention; EF: ejection fraction. 
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Data collection 
Clinical follow-up of the participants was performed according to routine practise at the 
intervention centres, and there were no per-protocol follow-up visits. Clinical data were 
retrieved from the patients’ electronic medical records by specially trained registered nurses. 
A study coordinating centre at the Institute of Clinical Medicine, UiT The Arctic University 
of Norway, collected the follow-up data using mailed questionnaires. Patients were sent 
reminders by phone and letter to complete and return their questionnaires. 
Data management 
NorStent stores the data in EUTRO, a database developed in 2004 by UiT The Arctic 
University of Norway. EUTRO ensures the safety, handling and management of sensitive 
research data and biological material in accordance with Norwegian research legislation and 
the regulations of The Norwegian Data Protection Authority. We received anonymous and 
only predefined data from EUTRO approved by the NorStent steering committee. Data 
management and statistical analyses were performed using IBM SPSS Statistics for Windows, 
version 23-26. (IBM Corporation, Armonk, New York). 
Study variables 
Age, gender, weight, cardiovascular medical history, cardiovascular risk factors and, current 
cardiac status were collected before the interventional procedure (index event), and 
medication at discharge was collected from the discharge notes. Educational level was 
collected 6 months after the index event and living arrangements at two years of follow-up. 
Age is presented as a categorical variable in the descriptive analyses, while in the regression 
model age is categorized as ≤59 years, 60-69 years and ≥70 years (Papers I-II) and as <50 
years, 50-55 years and 56-59 years (Paper III). Living arrangements are categorized as living 
alone, living with a spouse/partner or living with others (Paper I), and dichotomized in the 
regression model as living alone or with a spouse/partner (Papers I-III).  Smoking was self-
reported and categorized as never smoker, former smoker and current smoker (defined as 
daily smoker or having stopped smoking less than 30 days ago). Educational level was 
presented as a dichotomous variable: ≤12 years of education (primary school and/or high 




presented as a categorical variable (Paper I) and as a dichotomous variable (Papers I-III) with 
a cut-off of >25 Kg/m2 (overweight). Left ventricular ejection fraction was dichotomized with 
a cut-off of ≤40%. Geographical affiliation was based on the participants’ local hospital and 
then categorized in one of the four Norwegian Health Authorities.   
3.4.1 Cardiac rehabilitation (Papers I-III) 
Attendance in a CR programme during the period from baseline to 36 months after the index 
event was assessed by asking study participants the following questions, representing two 
possible CR alternatives: (1) Have you participated in a short ambulatory CR programme 
lasting for hours or days? (2) Have you participated in a hospital- or centre-based in-patient 
CR programme lasting for one or more weeks? The response options were ‘yes’, ‘no’, or 
‘uncertain’. Participation in CR was coded as “yes” if the patient answered ‘yes’ to one or 
both questions, and “no” if the patient answered ‘uncertain’ or ‘no’ to both questions. 
Assessment of CR participation by self-report has been validated in a previous study showing 
almost perfect agreement between self-reported and site-verified CR participation (136). 
Table 3 shows differences in baseline characteristics between participants in CR <1 week and 
CR ≥1 week. The similarities between the groups and content described in these two CR 











Table 3.  Baseline characteristics according to duration of cardiac rehabilitation  
Characteristic <1 week ≥ 1 week 
(n = 1016) (n = 933) p-value
Age  (years ± SD) 61 ± 9.5 59 ± 9.5 <0.001 
Male gender, n (%) 763 (75.1) 710 (76.1) 0.635 
Living alone, n (%)  168 (17.4) 169 (19.3) 0.305 
Educational level ≤12 years, n (%) 603 (61.0) 559 (62.2) 0.636 
Current smoker, n (%) 350 (34.4) 349 (37.4) <0.001 
Body mass index >25 kg/m2, n (%) 578 (66.2) 566 (70.4) 0.064 
Medical history, n (%) 
Prior myocardial infarction 59 (5.8) 61 (6.5) 0.109 
Diabetes mellitus 82 (8.1) 119 (12.8) 0.002 
Prior CABG surgery 22 (2.2) 32 (3.4) 0.098 
Prior stroke 17 (1.7) 33 (3.5) 0.023 
Prior lipid-lowering treatment 502 (49.4) 470 (50.4) 0.907 
Prior HT treatment 351 (34.5) 358 (38.4) 0.206 
Left ventricular EF ≤40%, n (%) 33 (12.7) 31 (9.0) 0.181 
Indication for PCI, n (%) 
Stable angina 123 (12.2) 174 (18.8) <0.001 
Acute coronary syndrome 891 (87.7) 758 (81.2) - 
Values are means (SD) or n (%). 
SD: standard deviation; CR: cardiac rehabilitation; CABG: coronary artery bypass graft; HT: 
hypertension; PCI: percutaneous coronary intervention; EF: ejection fraction.  
3.4.2 The Hospital Anxiety and Depression Scale (Paper II) 
Patient-reported symptoms of anxiety and depression were measured using the Hospital 
Anxiety and Depression Scale (HADS) in a representative sample of 775 patients at baseline 
and in all patients at 36 months follow-up (Paper II). HADS was developed by Zigmond and 
Snaith in 1983 to separate symptoms of anxiety and depression from symptoms caused by 
physical illness. The HADS therefore systematically excludes physical symptoms that can be 
mistaken for heart disease (137). For increased sensitivity to mild physiological issues and to 
avoid underreporting of stigmatized psychological symptoms, linguistic metaphors were used 
in structuring the questions (137).  
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The HADS is a self-rating instrument and takes only minutes to complete. It consists of a 
seven-item subscale for anxiety (HADS-A) and a seven-item subscale for depression (HADS-
D). HADS-A reflects symptoms of worry and restlessness, while HADS-D reflects inability 
to feel pleasure (anhedonia) and covers two of the three diagnostic criteria for depression in 
the International Classification of Disease (ICD-10).  
All questions have four-point response options, ranging from no points for no symptoms to 
three points for the maximum number of symptoms. The scores on each subscale range from 
0 to 21 points. Lower scores reflect a lower symptom presence (137). The HADS has 
demonstrated good psychometric properties across various patient samples and settings (138, 
139). As appropriate in instruments that use unweighted sum scores, simple mean imputation 
was performed when the respondent had answered at least four of the seven items in each 
subscale (140). Table 4 shows internal consistency in subscales and missing data before 
imputing missing items. A Cronbach’s alpha of ≥0.8 indicates good overall reliability of the 
questionnaire (141). A cut-off score of eight on the subscales was used in the analysis and has 
been found to provide an optimal balance between sensitivity and specificity for identifying 
possible or probable cases of clinically relevant symptoms of anxiety and depression (138), 
with scores <8 representing no symptoms of anxiety or depression. The expected HADS-A 
and HADS-D scores in the general population, presented as a continuous scale, were 
calculated using previously developed formulas based on the Norwegian general population, 




Table 4. Description of subscales, internal consistency and missing data without and with missing 
imputation at baseline and three years follow-up# 
 HADS-Anxiety HADS-Depression 
Items per subscale 
Cronbach’s alpha baseline 
Cronbach’s alpha 3 years 
Missing data without missing imputation baseline, n (%)  
Missing data with missing imputation baseline, n (%) 
Missing data without missing imputation 3 years, n (%)  
Missing data with missing imputation 3 years, n (%) 
   7 
   0.86 
   0.88 
  10 (1.3) 
    0 (0) 
188 (2.7) 
  19 (0.3) 
   7 
   0.80 
   0.84 
   9 (1.2) 
   0 (0) 
111 (1.57) 
  14 (0.20) 
HADS: The Hospital Anxiety and Depression Scale 
# This analysis includes 775 patients who were examined with the HADS both at baseline and at three years follow-up 
 
3.4.3 The Norwegian reference population (Paper II) 
The Norwegian reference population comprised participants in the second wave of a large 
population-based general health survey, the 1995-1997 Nord-Trøndelag Health Study (the 
HUNT 2 Study). A total of 66 140 individuals participated in the study, and 71% of those 
invited were aged ≥20 years. In Paper II we compared the results on symptoms of anxiety and 
depression measured with the HADS among PCI patients with the results from 54 867 
subjects without previous self-reported cardiovascular disease (142).  
3.4.4 Employment status (Paper III) 
Employment status 36 months after the index event was ascertained by asking the study 
participants if they were currently employed full-time or part-time, unemployed, retired on a 
disability pension, or on sick leave full-time or part-time, or if they were homemakers. 
Employment status was categorized as ‘employed’, ‘unemployed’ or ‘retired’. Being 
employed was classified as employed full-time or part-time. Being unemployed was classified 
as unemployed or on sick leave full-time or part-time. Retired participants were those that 
reported receiving a full-time or disability pension. Combinations of the employment status 
response were categorized as presented in Table 5, showing that most of the responses were in 
the main categories. 
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Table 5. Categorization of different combinations of the employment status response in the 
entire cohort, and numbers of participants in each category (n=7068) 
Numbers Employment status Category 
 29 Missing - 
78 Homemaker 0 
53 Unemployed 0 
2 Unemployed and employed full-time 0 
5 Unemployed and employed part-time 0 
1 Unemployed and homemaker 0 
52 Sick leave part-time 0 
7 Sick leave part-time and employed full-time 0 
23 Sick leave part-time and employed part-time 0 
9 Sick leave part-time and retired 0 
3 Sick leave part-time and retired and employed part-time 0 
113 Sick leave full-time 0 
11 Sick leave full-time and employed full-time 0 
3 Sick leave full-time and employed part-time 0 
2 Sick leave full-time and homemaker 0 
4 Sick leave full-time and unemployed 0 
1 Sick leave full-time and part-time and employed full-time 0 
1798 Employed full-time 1 
339 Employed part-time 1 
1 Homemaker and employed part-time and employed full-time 1 
13 Retired and employed full-time 1 
361 Retired and employed part-time 1 
1 Retired and employed full-time and employed part-time 1 
4128 Retired 2 
6 Retired and homemaker 2 
1 Retired and homemaker and employed full-time 2 
13 Retired and unemployed 2 
10 Retired and sick leave full-time 2 
1 Retired and sick leave full-time and employed part-time 2 
 0: Unemployed, 1: Employed, 2: Retired 
Statistical analysis 
3.5.1 Descriptive statistics 
Descriptive statistics of continuous variables were performed using interquartile range (Paper 
I), means and standard deviations (SD) (Papers I-III). Categorical variables were analysed as 
absolute numbers and percentages (Papers I-III). 
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3.5.2 Comparisons 
Differences in baseline characteristics were assessed using Pearson’s chi-square or 
independent samples Student’s t-test, as appropriate (Papers I-III). Between-group 
comparisons were performed using the independent samples t-test (Papers I-II) or conditional 
logistic regression (Paper III), and within-group comparisons were performed using paired 
sample t-tests (Paper II). Differences between the observed scores in the study population and 
the expected scores in the general population were analysed using the one-sample t-test 
(Paper II). For all three studies, a two-tailed p-value of <0.05 was considered statistically 
significant.  
3.5.3 Regression 
Univariate and multivariate logistic regression analysis was used to identify predictors of CR 
participation (Paper I), symptomatic anxiety and depression (Paper II) and for being 
employed three years after PCI. The multivariate model was built using independent variables 
that had a statistically significant unadjusted association (Paper I), variables associated with 
symptoms of anxiety and depression (Paper II) or severity of CHD in previous research 
(Papers I-III). All models were tested for goodness of fit using the Hosmer-Lemeshow test 
that compares the prediction model to a hypothetically perfect model. A non-significant 
difference is desirable as it indicates that the model being tested is not reliably different from 
the perfect model (141, 143). Interactions are concerned with whether the effect of the 
independent variable is consistent for all levels of a second independent variable, common for 
gender and age (141, 143). In Paper I, all significant two-way interactions were tested in the 
full multivariate model. Only HA×age remained significant and stratified analyses were 
performed. In Paper II and III, two-way interactions between the independent variables and 
gender and age were tested. No interactions were found. 
3.5.4 Propensity score 
An RCT is the gold standard for estimating the effects of treatments on outcomes. In an RCT, 
patients are randomly assigned to either a treatment or a control group. In observational data, 
there is a chance of systematic differences between patients receiving and not receiving 
treatments. These differences are attempted to be controlled for using multiple regression or 




because the patients are not real candidates for both treatments or they can give a large 
proportion of unmatched patients (144-147). 
Propensity scores (PS) reduce the covariate to a single quantity, and as a result, patients with 
similar propensity scores in different treatment groups can be compared as they have the same 
probabilistic distribution (144-147). A patient’s propensity score is defined as ‘the probability 
that the patient receives treatment A (instead of B), given all relevant conditions, 
comorbidities, and other characteristics at the time the treatment decision is made’ (145). 
We produced a PS to compare CR participants and non-participants on symptoms of anxiety 
and depression (Paper II) and employment status (Paper III). The PS was calculated for each 
participant using a logistic regression model with predefined baseline covariates related to the 
outcome and based on previous literature and scientific understanding. The following 
variables were included: age, gender, educational level, smoking status, BMI, prior MI or 
coronary artery bypass graft, diabetes mellitus, prior lipid-lowering treatment, prior 
hypertension treatment, regional health authority and indication for PCI (Papers II and III), 
and creatinine concentration and left ventricular ejection fraction (Paper II). 
The PS was calculated without replacement and we used one-to-one matching with a calliper 
of 0.02. Covariate balance was checked as recommended for studies reporting PS analysis 
using binary statistics and standardized mean difference (145, 147). The analysis was 
performed using SPSS version 26 with the Statistics Regression module, the Python 
Essentials and version 1.3.0 of the FUZZY extension command (IBM Corporation, Armonk, 
New York). 
 Ethics 
The study conforms with the principles outlined in the Declaration of Helsinki and the UN 
Declaration of Human Rights (148). All patients gave written informed consent to participate 
in the study and were informed about the opportunity to withdraw their consent at any time 
without giving any particular reason. Study participants received the same medical treatment 
as if they were not participating in the trial and the treatment was performed according to 
routine hospital practice. NorStent has been reviewed and approved by the Regional 
Committee for Medical and Health Research Ethics in Northern Norway 
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(PREKNORD40/2008) and the Norwegian Social Science Data Services (NSD19480) and is 
registered in ClinicalTrials.gov (NCT00811772).  
3.6.1 Funding 
The Research Council of Norway and other non-profit organizations founded NorStent, and 
the Northern Norway Regional Health Authority (Grant number SFP1233-15) founded the 
PhD project. 
3.6.2 User involvement 
The idea of this study arose from years of experience working with patients with established 
CHD. This was in combination with collaboration with health professionals in Norway and 
abroad. The former patients, i.e. the participants in the clinical NorStent study, are not directly 
involved. However, the use of patient-reported outcome measures and research topics that are 
important for the patients’ well-being leads us to believe that our research is in line with the 




4 Summary of results 
 Paper I 
Cardiac rehabilitation after percutaneous coronary intervention: Results from a 
nationwide study 
At three years follow-up, 27.6% of the participants reported having participated in a CR 
programme. There were geographical differences in participation rates between the health 
regions in Norway (20%-31%). Compared to non-participants, the typical CR participant was 
younger, had a higher educational level, currently smoked, had a lesser degree of 
cardiovascular disease and to a greater extent had acute coronary syndrome as the indication 
for PCI.  
In multivariate adjusted analysis, CR participation was associated with higher levels of 
education (OR 1.50; 95% CI 1.32-1.71), overweight (OR 1.19; 95% CI 1.05-1.36), an acute 
coronary event (OR 3.23; 95% CI 2.76-3.79), while the probability of participating in CR 
decreased with increasing age. Male gender (OR 0.72; 95% CI 0.62-0.83) and prior MI or 
CABG (OR 0.71; 95% CI 0.55–0.91) were associated with less likelihood of CR 
participation. 
When stratified by regional health authorities, the regression model showed that chronological 
age was a predictor for non-participation in all regions, and that an acute coronary syndrome 





Cardiac rehabilitation and symptoms of anxiety and depression after percutaneous 
coronary intervention 
We found that 27% and 19% of patients reported clinically relevant symptoms of anxiety and 
depression, respectively, the week before PCI, with the highest levels found in those 
participating in a CR programme. After three years, both the CR participants and non-
participants had a higher mean level of symptoms of anxiety than the reference population. 
For symptoms of depression, the CR participants had a higher and the non-participants a 
lower mean score than the reference population. Changes in HADS-A and HADS-D represent 
a significant reduction (p<0.001) from baseline to three years follow-up. 
In a separate analysis of the total cohort of 7068 patients, the HADS-A score after three years 
of follow-up was significantly higher than that in the reference population (3.92 (SD: ±3.63) 
vs 3.44 (SD:±0.45), p<0.001), while the HADS-D score was significantly lower (3.42 (SD: 
±3.44) vs 3.85 (SD: ±0.48), p<0.001). 
There were no differences in change of symptoms of anxiety and depression between the CR 
participants and non-participants (HADS-A; p-value= 0.396 and HADS-D; p-value= 0.607). 
In the propensity-matched cohort, CR participants had more clinically relevant symptoms of 
anxiety, but not depression (p-value = 0.003 and 0.207, respectively).  
Multivariate adjusted analysis showed that male gender (OR 0.45; 95% CI 0.35-0.58) and 
older age (p<0.001) were associated with lower probability of clinically relevant symptoms of 
anxiety, whereas CR participation was associated with higher probability of clinically relevant 
symptoms of anxiety (OR 1.47; 95% CI 1.12-1.95). Higher levels of education (OR 0.71; 
95% CI 0.53-0.95) and an acute coronary event as the indication for PCI (OR 0.73; 95% CI 
0.56-0.95) were associated with lower risk of clinically relevant symptoms of depression. 
Older age (p-value=0.016), former smoking (p-value=0.012) and prior cardiovascular disease 
were associated with higher risk of clinically relevant symptoms of depression (prior 
MI/CABG; p=0.045, prior stroke; p= 0.011). 
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Paper III 
Employment status three years after percutaneous coronary intervention and predictors 
for being employed. A nationwide prospective cohort study. 
At three years follow-up, 2488 patients were of working age. The majority of these were 
employed (70.2%), while 11.2% were unemployed and 18.6% were retired. 38.3% of the 
patients reported having participated in a CR programme at some point during the period 
from baseline to 36 months.  
In the propensity-matched cohort, employment status of the CR participants did not differ 
from that of the non-participants (p=0.580). The multivariable-adjusted analyses showed that 
male participants (OR 1.93; 95% CI 1.50-2.50), participants living with a partner (OR 1.40; 
95% CI 1.07-1.82), and participants with a high level of education (OR 1.93; 95% CI 1.54-
2.42), had a significantly higher chance of being employed three years after PCI. In addition, 
participants living in western Norway were most likely to be employed, while those in 
northern Norway had the lowest employment rate (OR 1.89; 95% CI 1.32-2.71). Higher age 
(p<0.001), former smoking (p=0.01), prior MI or CABG (OR 0.55; 95% CI 0.37-0.81), and 
prior hypertension treatment (OR 0.69; 95% CI 0.55-0.86) were associated with a lower 
chance of being employed. 
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5 Discussion of methodology 
Study design 
The present thesis aims to answer the research questions with a prospective observational 
study design, where we follow a cohort of CHD patients from their first PCI to three years 
later. A causal relationship exists if the cause comes before the effect, the cause was related to 
the effect, and we cannot find alternative explanations for the effect other than the cause 
(149). The papers in this thesis have both a non-experimental and quasi-experimental design 
with several methods to describe the situation, prove an association or prove a causal 
relationship, as shown in Table 7.  
Table 7.  Design used to prove a causal relationship in the present thesis 
Research question Design 





Paper II Determine proportions 
Determine predictors 
Compare proportions 
between two groups 




Post-test with propensity score matching 
Pre-test and post-test  




Paper III Determine proportions 
Determine predictors 
Compare proportions 
between two groups 
Descriptive 
Correlational 
Post-test with propensity score matching 
Non-experimental 
Quasi-experimental 
A prospective non-experimental design has the benefit that it can be used for large samples, 
with lower costs and with long-term follow-up, and it is strong in realism (149, 150). When 
estimating the proportion of patients participating in CR who had symptoms of anxiety and 
depression or their employment status, we used descriptive methods where the purpose is to 
observe, describe, and document aspects of a situation (150). Findings from descriptive 
studies can serve as a starting point for hypothesis generation for use in future research (150). 
It is also an alternative when it is unethical to offer an intervention to one group, but not the 
other (149, 150). CR has a Class I recommendation with Level A of evidence for patients 
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with CHD (37, 151, 152). This would represent an ethical challenge for us in conducting an 
RCT. We chose to improve the prospective observational study design by adding propensity 
score matching to our non-equivalent groups (CR yes and CR no). This method strengthens 
the design and is therefore referred to as quasi-experimental (149, 150).  
The validity of the study must be considered in interpreting the results, and possible threats 
need to be addressed. Validity is not an absolute, but a matter of degree (150). A taxonomy of 
four types of validity was introduced by Shadish et al.: statistical conclusion validity, internal 
validity, construct validity and external validity (149). The present study has many strengths, 
such as a large representative sample, the prospective study design, the long-term follow-up, 
and the high response rate. We have made efforts to improve the validity of our findings and 
to reduce the risk of threats. Despite these strengths, there are some limitations to take into 
consideration. Strengths and limitations are therefore discussed in more detail in the next 
sections. 
5.1.1 Statistical conclusion validity 
Statistical conclusion validity concerns the validity of inference that there truly is an 
association between the assumed cause and effect. Decisions about research design can 
protect against reaching false statistical conclusions. Type I errors occur when the researcher 
concludes that there is an association or effect, when there is not (149, 150). A two-tailed p-
value of <0.05 was considered statistically significant in the present thesis, implying that 5% 
of the association or effect occurs by chance alone (representing a 5% probability of 
committing a type I error). A type II error occurs when the researcher concludes that there is 
no association or effect, when in fact there is (149, 150). The level of statistical significance 
and the large sample size increase the chances to capture the true differences in the statistical 
tests, and we believe that there is a good balance between the probabilities of committing a 
type I and type II error. 
The large sample size gives us better precision through powerful statistical methods that 
attempt to control confounding variables. Confounders are common in observational studies 
and can suggest that there is an association between the exposure and the outcome where 
there is none, or mask a true association (150). In Papers I-III, we used multivariable 




outcome, as further described in the papers. Notably, because of the high correlation between 
symptoms of anxiety or depression, we did not control for depression when analysing anxiety 
or vice versa, as this could cause a disproportionate weakening of the association (Paper II). 
However, a sub-analysis where we categorized the response >8 in HADS-A, HADS A+D and 
HADS-D could have given us further information about the presence of the combination of 
anxiety and depression in our population.  
In Paper I, we used stratification when analyses differed between regional health authorities. 
Both stratification and statistical adjustment can reduce the risk of confounding (150). 
Unfortunately, we could not control for previously diagnosed anxiety and depression 
disorders and treatment with antidepressants (Paper II) or employment status at baseline 
(Paper III). In addition, not knowing the content and level of CR, especially in terms of 
physical activity and vocational and psychological support, may have influenced our findings.  
In Papers II and III we used propensity matching scores, in which potential confounders are 
used to build a statistical model where we reduce the covariate to a single quantity called the 
propensity score: the participants with high scores are more likely to have certain 
confounders, while those with low scores are less likely. The matching allows us to compare 
participants with the same ‘level’ of confounders. Nevertheless, despite the use of statistical 
methods that reduce the chance of confounding, unknown factors may still be significant 
residual confounding factors and present in all papers. 
5.1.2 Internal validity 
Internal validity implies the validity of inferences that, given that an empirical association 
exists, it is the independent variable that caused the outcome. Quasi-experimental and 
descriptive studies are especially vulnerable to threats to internal validity (149, 150). Bias is a 
problem that threatens internal validity. Bias is a systematic deviation from the truth that 
produces a distortion in the study results. Bias can seldom be avoided, but through systematic 
analysis and careful implementation of findings, bias can be reduced to a minimum (150). In 
the present thesis, internal validity of our results needs to be seen in light of selection bias, 




As NorStent was developed to evaluate the long-term risk and benefits of the use of drug-
eluting stents versus bare metal stents in a large, randomized trial, this might have influenced 
the selection of the patients included in the study. For example, 1732 patients were not 
enrolled in the study because of physicians’ stent preference. This could happen in situations 
where the patients were diabetic, had long stenosis or small vessels, and were randomized to 
bare-metal stents. This indicates that selection bias is probably present to some extent, as 
these patients are often complex CHD patients and women. In addition, patients that refused 
to participate in the study or were not enrolled for unknown reasons (2260 patients) might 
have been those with severe presentation of the coronary event. Lack of time to enrol the 
patient or for the patient to take a decision on participation in the study before the index PCI 
may have excluded patients eligible for our analysis. However, 73% of patients with protocol 
eligibility were included, and the large nationwide sample size, reduced the risk of selection 
bias in our cohort substantially.  
Attrition bias 
Attrition bias is a possible source of bias in our study, especially given the long follow-up 
time. Attrition occurs when the characteristics of those who remain in the study differ from 
those of the drop-outs (150). It is recommended to have <5% attrition as this leads to little 
bias. The present study had a response-rate of 82% excluding the patients that died during 
follow-up, giving us less than 20% loss and an intermediate level of threats to validity (153). 
The study design makes it unlikely that participants left the study for reasons related to the 
outcome, and this therefore had little impact on the results. However, some differences are 
present between those lost to follow-up and those participating at three years follow-up. 
Overall, the participants that dropped out were younger, lived alone, had a lower educational 
level, were current smokers, had a higher degree of comorbidities and had an acute coronary 
syndrome at index event (Table 2). These patient characteristics are at some extent typical for 
non-attendees in CR programmes (79), and the CR participation rate presented in Paper I may 
therefore be even lower. The prevalence of symptoms of anxiety and depression in Paper II 
may also be higher, as drop-outs more often have depression, anxiety and negative affectivity 
than completers (154).  
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Recall bias 
In self-reporting, the respondent must comprehend the question being asked, recall 
information from memory, make a decision about the accuracy of the information recalled 
and formulate an answer (155). Recall bias is a problem in studies that have self-reporting and 
can be greater when the time interval being asked about is longer. Responders tend to under-
report the severity of past problems (140). Research has shown that it is less common for a 
person to wrongly remember an event that did not occur (156). The present thesis assessed 
CR participation by self-report as there is no national register or standard use of ICD codes in 
institutions offering CR. Assessment of CR participation by self-report has been validated in a 
previous study, showing almost perfect agreement between self-report and site-verified CR 
participation (136), suggesting that recall bias regarding CR participation is less likely in this 
study. In Paper II, the participants were asked about symptoms of anxiety and depression in 
the period before hospitalization approximately nine weeks after inclusion. This delay in time 
could have influenced their answers in a positive direction, but our participants scored worse 
compared to the general Norwegian population. 
Instrument bias 
When using self-report instruments, people often tend to present themselves in a favourable 
light (155). As the present data were collected by mail or phone, there is a smaller risk that the 
participants modify their answers, compared to having an in-hospital interview. The HADS 
demonstrated adequate reliability in the present study (Cronbach’s alpha >70). The HADS is 
validated for use in a CHD population and, in contrast to diagnostic interviews and other self-
reported instruments regarding mental health, the HADS systematically excludes physical 
symptoms that can be mistaken for heart disease (137). This, in addition to the use of the 
recommended cut-off value, strengthens the chance of detecting the true prevalence of 
clinically relevant symptoms of anxiety and depression.   
Regarding employment status, we chose to categorize the variables following Harrison et al. 
(157). Due to timeline and costs, it was not possible to link our data with the National 
Insurance Registry. We therefore chose a strict age limit to ensure that the patients included in 
our analysis were retired because of health issues, and not age.   
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5.1.3 Construct validity 
Construct validity refers to the degree to which inferences can legitimately be made from the 
operationalizations in the study to the theoretical constructs on which those 
operationalizations were based (149, 150). Although there is a consensus internationally on 
what should be the content of CR, there is a great variation in what is being offered (85, 86). 
The CR variable in this study was merged as we wanted to determine whether there were 
differences between participants receiving no follow-up care and those receiving some. There 
is a possibility that participants that answered ‘no’ to CR participation had received some 
form of follow-up care that is in the concept of CR, but not named CR. Furthermore, when 
analysing the effect of CR, there is a risk of contamination as non-participants may also adopt 
a healthier lifestyle. In addition, both CR participants and non-participants could have been 
influenced by national campaigns promoting physical activity, a non-smoking environment 
and healthy dietary habits. Anticipating a threshold in how much people will improve their 
lifestyle could explain the lack of differences between CR participants and non-participants. 
5.1.4 External validity  
External validity is the extent to which the results can be generalized to other settings, time, 
populations or measures of the outcomes (149, 150). The NorStent was performed at all 
centres in Norway that perform PCI, thus covering the total Norwegian population of more 
than 5 million inhabitants. The clinical setting and a multi-centre approach strengthen the 
external validity (149, 150). We believe therefore that the findings of our study are 





6 Discussion of main results 
This study has revealed that few patients with established CHD participate in a CR 
programme, with certain geographical differences. We also found that 27% and 19% of 
patients who had undergone PCI reported symptoms of anxiety and depression, respectively, 
with the highest levels found in those participating in a CR programme. There were no 
differences in changes in symptoms of anxiety and depression between the CR participants 
and non-participants. After three years, both the CR participants and non-participants had a 
higher level of anxiety, but not depression, than the general Norwegian population. In 
addition, we found that 70% of participants aged 62 years and younger reported being 
employed three years after PCI. These individuals’ employment status was not aided by CR 
participation. Finally, the study reported several patient characteristics related to future 
likelihood of CR participation, long-term symptoms of anxiety and depression, and being 
employed after PCI. 
 Cardiac rehabilitation participation 
Only 28% of the study participants reported having participated in a CR programme, which is 
lower than the European average (6, 7). In Norway, Peersen et al. found a large difference in 
participation rates between two nearby hospitals, Drammen and Vestfold (18% vs. 75%, 
respectively) (87). Vestfold has inpatient referral and start-up after two weeks, while 
Drammen has suboptimal availability and referral procedures (87). Lack of national standards 
and guidelines for CR represents a system barrier in Norway and CR delivery varies 
considerably. We found differences between the four regional health authorities, which may 
be due to differences in financial support, availability and referral practice. In addition, the 
scientific doubt as to the effect of CR coupled with the successful effect of medications on 
coronary risk factors may contribute to barriers to provision and low numbers of referrals.  
In a qualitative study from Norway, PCI patients described a stressful hospital environments 
and little information about their diagnosis and consequences of the disease. They therefore 
sought information from friends, newspapers and the Internet (158). Patient-related barriers 
and lack of awareness and perceived need can explain low participation rates. We found less 
likelihood of CR participation among older patients and patients with a lower educational 
level, which are known characteristics of people at risk of limited health literacy (57, 58). The 
fact that many of the CR programmes are named ‘Heart School’ can act as an barrier to 
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patients with negative associations to school as they might think that they will be tested or 
need to prove their knowledge there.  
Compared to northern Norway, patients in central and southern/eastern parts of the country 
were more likely to participate in a CR programme. In stratified analysis, we found that 
young age, higher educational level and an acute coronary event as indication for PCI were 
the strongest predictors of CR participation in all regions. In Norway, patients undergoing 
planned PCI stay in hospital for one day on average, while those with acute coronary 
syndrome stay for two to four days. The short hospital stay after PCI with limited time for 
health information may increase the distinction in CR participation between patients with low 
and high health literacy. Patients with a higher degree of health literacy tend to seek 
information about the beneficial effects of CR and to request this kind of treatment. 
In contrast to previous research, our multivariate analysis showed that women were more 
likely to participate in a CR programme than men (79, 159), perhaps because of an increasing 
focus in recent decade on women’s cardiovascular health. Previously, many domestic tasks 
had been suggested as a barrier for women to participate in CR, but this might be less of an 
issue today. Overweight patients and those with an acute coronary event were more likely to 
participate in CR. This may be a combination of individuals’ desire to optimize their lifestyle 
and the fact that clinicians can more easily identify such patients’ risk of future CHD events. 
Prior CR participation may explain why patients with prior MI or CABG less often report 
engaging in CR. 
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Symptoms of anxiety and depression and cardiac rehabilitation 
Previous research on the prevalence of symptoms of anxiety and depression both in the 
general population and in CHD patients has varied in design, measurement methods and 
accordingly prevalence estimates (93, 94, 104, 107-109). The present study revealed a higher 
prevalence of symptomatic anxiety and depression at the index event than reported in 
previous studies of CHD patients from Nordic countries. Our prevalence was consistent with 
the mean results in Europe (104, 105, 107), and lower than that reported in a PCI population 
(111). Variation in severity of anxiety and depression over a lifetime and differences in 
methods to measure symptoms of anxiety and depression may partly explain the 
dissimilarities.  
When investigating levels of symptoms of anxiety and depression in a CHD population, it is 
interesting to compare the levels with the general population. We found that at the index 
event, both CR participants and non-participants had higher levels of anxiety than expected in 
the general population. This may be due to the patients’ recent diagnosis of CHD, sometimes 
presented or perceived as a life-threatening event. At three years follow-up, the levels of 
symptoms of anxiety had decreased significantly in the study population. This change 
represents a minimal clinically important difference, as the threshold for CHD patients is 
reported to be 1.7 points (160). However, it was still higher than expected in the general 
population, but not statistically significant among the non-participants. We also found a 
statistically significant higher level of anxiety in the total cohort three years after PCI 
compared to the general population. These findings may indicate that some of the study 
participants had a generalized anxiety disorder with more persistent symptoms. 
We found no differences in changes in symptoms of anxiety between the CR participants and 
non-participants, but when we compared the propensity-matched groups, more CR 
participants reported clinically relevant levels of anxiety three years after PCI. We do not 
believe that CR promotes anxiety, but that healthcare professionals identify and encourage 
anxious patients to participate in a CR programme. Furthermore, if there is limited availability 
on CR programmes, patients in most need are given priority. As previously shown (104, 109), 
the multivariate analysis revealed that women and younger patients were associated with 
symptomatic levels of anxiety three years after PCI. Notably, the unadjusted analysis showed 
that patients living alone, currently smoking, and with a lower educational level, had a higher 
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risk of clinically relevant symptoms of anxiety three years after PCI, which is characteristic of 
patients with lower socioeconomic status and limited health literacy (57, 58, 161).  
Regarding symptoms of depression, the level of symptoms in both CR participants and non-
participants were higher than expected compared to the general population. As depression is a 
risk factor for CHD, these findings were as expected. Surprisingly, the CR participants had 
similar levels to the expected score of the general population after three years, and the non-
participants had significantly lower levels of symptoms of depression. Also in the total study 
population, we found lower levels of depression than those expected in the general 
population. The normal variation in severity of depression can be one explanation, but we 
cannot exclude the possibility that some patients received treatment for their depression 
during the follow-up period. The present study suggests that less educated and older patients 
are at risk of clinically relevant symptoms of depression, as also shown in previous research 
(104). We also found that patients with cardiovascular diseases, a history of smoking and 
acute coronary syndrome were at risk of clinically relevant symptoms of depression three 
years after PCI. This may indicate that these patients are living with an increased burden of 
the disease that influences the level of depression.  
As with symptoms of anxiety, there was no significant change in level of depression between 
CR participants and non-participants after three years. These findings were confirmed in the 
propensity-matched analysis, where we found no benefit regarding the level of clinically 
relevant symptoms of depression in CR participants. Unfortunately, we were unable to control 
for previously diagnosed anxiety and depression disorders, which may have affected the 
results. There is no robust evidence of the benefit of psychological interventions on symptoms 
of anxiety and depression, and reviews and meta-analyses may have been influenced to some 
extent by historically limited publications with negative findings (publication bias). However, 
as we have limited information about the content and level of physical and psychological 




 Employment status and cardiac rehabilitation  
We found that 70% of patients 62 years and younger reported being employed three years 
after PCI, slightly lower than in previous studies of CHD patients (120-122, 126). However, 
differences between previous studies and the present study regarding study population, 
severity of the coronary disease, employment status at inclusion and follow-up time make it 
difficult to compare our findings. Detachment is present in up to 24% of patients one year 
after return to work (121). This demonstrates the importance of long-term follow-up when 
measuring employment status after PCI and may explain a lower rate of employed patients in 
our study at three years follow-up compared to previous findings. In addition, the rate of 
employed patients in our study is somewhat lower than that reported in the general 
Norwegian population (119), indicating that our study population has health issues that may 
act as barriers to employment. 
This assumption is strengthened by the fact that about 19% of patients of working age 
reported that they were retired three years after PCI, demonstrating that approximately twice 
as many CHD patients leave the workforce early as in the general population (119). We lack 
information on the reasons for early retirement, but research has demonstrated that the most 
common reasons seemed to change from musculoskeletal disorders and mental disorders 
before an ischaemic heart disease event to diseases of the circulatory system after such an 
event (128). Despite improvements in the prognosis for CHD patients, there may still be a 
fear of a negative health impact because of the physical or mental stress involved in work. 
Furthermore, there might be less stigma related to disability due to CHD than musculoskeletal 
disorders. 
We did not have the opportunity to study change in employment status over time, as we 
lacked information on employment status at the index event and on subsequent morbidity 
during the three years. A history of long-term sickness absence prior to revascularization is, 
for example, a strong predictor of long-term sickness absence following PCI, followed by a 
disability pension (125, 127). We found that being male, living with a partner, and higher 
levels of educational attainment were associated with a greater chance of being employed 
three years after PCI. The beneficial association between educational level and return to work 
has previously been shown (120, 121, 125). Higher educational level may indicate a white-
collar job, previously known to facilitate return to work (132). Regarding gender differences, 
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previous research is more inconclusive, but most studies report that men are more likely to be 
employed than women are (120, 121, 124, 125, 129). We also found that older patients and 
those living in northern Norway had less chance of being employed. Fewer opportunities for 
retraining or changing the type of job can be one explanation, leading to a disability pension 
after long-term work incapacity. 
We did not find any differences in employment status in our propensity-matched comparison 
between those participating in CR and the non-participants three years after PCI. One 
limitation is that we could not control for employment status at index event. In addition, we 
do not know the content of the vocational training in the CR programmes. Differences 
between CR programmes regarding vocational support may explain some of the difficulty in 
finding an effect of CR on employment status. However, there appears to be little benefit of 
CR on employment status and a Cochrane review found no evidence that CR promotes return 
to work after one year follow-up (133). These findings were supported by two recent studies 
showing no association between CR or psychosocial and vocational interventions and return 
to work (124, 134). An ageing population will lead to a future need to keep as many people as 
possible employed and to stay in their jobs longer; vocational support may thus play a more 
central role in aftercare for CHD patients in the future. 
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7 Conclusions and future perspectives 
We believe that our findings provide a valid picture of parts of CR provision in Norway, and 
that our findings can serve as a starting point for future research. The design of this study, 
however, limits the possibility to find causal effects between CR and participation rate, 
clinically relevant symptoms of anxiety and depression or employment status.  
We found that the estimated CR participation rate in Norway is low. The typical CR 
participant in Norway is young, overweight, well-educated, and has suffered from an acute 
coronary event. We also found that the participation rate to some extent varied 
geographically. Despite a reduction in levels of symptoms of anxiety and depression after 
three years, we did not identify any beneficial effect of CR participation. However, the CR 
participants reported a clinically important decrease in symptoms of anxiety. Compared to the 
reference population, our patients had higher levels of anxiety, but not depression, three years 
after PCI.  
A significant number of working-age patients remain unemployed three years after their first 
coronary revascularization, indicating that employment status should be an important 
component of aftercare for PCI patients. However, we did not identify any beneficial effect of 
CR participation on employment status. Healthcare providers should pay attention to factors 
associated with clinically relevant levels of anxiety and depression and unemployment in PCI 
patients, to prevent long-term symptoms of anxiety and depression and future poor vocational 
outcome. The present study suggests that the patients most in need, i.e. those who are 
overweight, smokers, and have the highest levels of anxiety and depression, are identified and 
encouraged to participate in CR programmes. 
The beneficial effect of cardio-protective medications may have been at the expense of other 
initiatives that promote secondary prevention, although those without the strongest evidence 
on mortality and morbidity. However, from the patients’ perspective, mental health and social 
and vocational reintegration are important and associated with higher levels of medical and 
healthy lifestyle adherence. Greater acceptance by healthcare providers that CR facilitates 
secondary prevention may increase the referral and participation rates, which in turn may 
result in more patients achieving treatment goals in secondary prevention. National standards 
for secondary prevention goals, how to reach them and the role of CR programmes in 
secondary prevention therapy seem to be needed. In addition, we need high quality research to 
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prove the beneficial effect of CR in an era of improved pharmacological and interventional 
treatments, and to find the most efficient modes of delivery. 
The content of future CR must take into account the economic pressure on our health care 
system and a greater demand for tailored health services, recently mentioned in the 
Norwegian National Health and Hospital Plan 2020-2023 (162). Today, CR in Norway is 
practised as “one size fits all”, but with a great variety in the content of CR programmes 
between hospitals. A first step would be to gain an overview of all the CR programmes in 
Norway. Secondly, attempts should be made to ascertain the barriers to CR participation and 
achieving treatment goals in secondary prevention. Thirdly, patients that would benefit from 
the different modes of delivery must be identified. This should lead to a nationwide 
randomized controlled trial investigating both the ‘hard’ and ‘soft’ outcomes of CR. Finally, a 
national CR register should be established to continuously measure predefined quality 
indicators. All these initiatives should be planned by a multidisciplinary team and involve a 
mixed interventions approach in order to enhance understanding of all the aspects involved.
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Cardiac rehabilitation after  
percutaneous coronary intervention: 
Results from a nationwide survey
Siv JS Olsen1,2, Henrik Schirmer2,3, Kaare H Bønaa4,5,6 
and Tove A Hanssen2,3
Abstract
Aim: The purpose of this study was to estimate the proportion of Norwegian coronary heart disease patients participating 
in cardiac rehabilitation programmes after percutaneous coronary intervention, and to determine predictors of cardiac 
rehabilitation participation.
Methods: Participants were patients enrolled in the Norwegian Coronary Stent Trial. We assessed cardiac rehabilitation 
participation in 9013 of these patients who had undergone their first percutaneous coronary intervention during 2008–
2011. Of these, 7068 patients (82%) completed a self-administered questionnaire on cardiac rehabilitation participation 
within three years after their percutaneous coronary intervention.
Results: Twenty-eight per cent of the participants reported engaging in cardiac rehabilitation. Participation 
rate differed among the four regional health authorities in Norway, varying from 20%–31%. Patients undergoing 
percutaneous coronary intervention for an acute coronary syndrome were more likely to participate in cardiac 
rehabilitation than patients with stable angina (odds ratio 3.2; 95% confidence interval 2.74–3.76). A multivariate 
statistical model revealed that men had a 28% lower probability (p<0.001) of participating in cardiac rehabilitation, 
and the odds of attending cardiac rehabilitation decreased with increasing age (p<0.001). Contributors to higher 
odds of cardiac rehabilitation participation were educational level >12 years (odds ratio 1.50; 95% confidence 
interval 1.32–1.71) and body mass index>25 (odds ratio 1.19; 95% confidence interval 1.05–1.36). Prior coronary 
artery bypass graft was associated with lower odds of cardiac rehabilitation participation (odds ratio 0.47; 95% 
confidence interval 0.32–0.70)
Conclusion: The estimated cardiac rehabilitation participation rate among patients undergoing first-time percutaneous 
coronary intervention is low in Norway. The typical participant is young, overweight, well-educated, and had an acute 
coronary event. These results varied by geographical region.
Keywords
Cardiac rehabilitation, secondary prevention, coronary heart disease, myocardial infarction, coronary artery disease
Date received: 18 April 2017; revised: 26 September 2017; accepted: 27 September 2017
1Division of Internal Medicine, University Hospital of North Norway, 
Norway
2Cardiovascular Research Group, The Arctic University of Norway, 
Norway
3Department of Heart Disease, University Hospital of North Norway, 
Norway
4Department of Community Medicine, The Arctic University of 
Norway, Norway
5Department of Public Health and Nursing, Norwegian University of 
Science and Technology, Norway
6Clinic for Heart Disease, St. Olavs University Hospital, Trondheim, 
Norway
Corresponding author:
Siv JS Olsen, Division of Internal Medicine, University Hospital of North 
Norway, 9480 Harstad, Norway.
Email: sivolsen@hotmail.com
737766 CNU0010.1177/1474515117737766European Journal of Cardiovascular NursingOlsen et al.
research-article2017
Original Article
2 European Journal of Cardiovascular Nursing 00(0)
Introduction
Improved survival coupled with an increasingly ageing pop-
ulation has led to a growing number of people living with 
cardiovascular disease (CVD) and a growing need for medi-
cal follow-up. Cardiac rehabilitation (CR) makes an impor-
tant contribution to secondary prevention of cardiac events. 
The World Health Organization defines CR as ‘The sum of 
activities required to influence favourably the underlying 
cause of the disease, as well as to ensure the best possible 
physical, mental and social conditions, so that they may, by 
their own efforts, preserve or resume when lost as normal a 
place as possible in the life of the community’ (p. 5).1 
According to international guidelines, CR should be a 
core component of the care received by patients with 
established coronary heart disease (CHD).2,3 The ele-
ments of CR consist of lifestyle interventions, risk factor 
management, and psychosocial and vocational support.4 
The short-term goals for CR are to manage cardiac 
symptoms, improve functional capacity, limit psycho-
logical distress, and give vocational support to the 
patient. The long-term goal is to stabilise or slow the 
progression of arteriosclerosis, thereby reducing mor-
bidity and mortality, and minimising the risk of future 
cardiac events.5
Despite scientific doubt, a recent meta-analysis showed 
that CR in patients with established CHD is associated 
with reductions in cardiovascular mortality and hospital 
admissions, and improved quality of life.6 Despite the evi-
dence of benefits, referral to and participation in CR pro-
grammes vary widely across Europe.7,8 In Norway, 
availability of CR varies widely within geographical 
regions and across the country.9,10 In addition, acute myo-
cardial infarction (MI) patients require more information 
after discharge,11 and experience discontinuity of care after 
percutaneous coronary intervention (PCI).12 Furthermore, 
no national estimates exist on the proportion of patients 
participating in CR programmes.
The aims of this study were to determine the approxi-
mate proportion of Norwegian cardiovascular heart dis-
ease patients participating in CR programmes after PCI 
and to determine predictors of CR participation.
Methods
Design and settings
The present study uses an observational cohort design and 
is a substudy of the Norwegian Coronary Stent Trial 
(NorStent). NorStent is a nationwide, multicentre, ran-
domised controlled trial conducted at all PCI centres in 
Norway. Its primary objective is to compare the effect of 
drug-eluting and bare-metal stents on long-term mortality 
and cardiovascular morbidity.13 Clinical variables and 
patient-reported outcomes were collected at baseline and 
three years after the PCI procedure.
Study participants
Patients were included in NorStent from September 
2008–February 2011. In addition to the ability to commu-
nicate in Norwegian and having a Norwegian personal 
identification number, patients were included if this was 
their first PCI due to either stable angina or acute coro-
nary syndromes, were at least 18 years old, had a lesion in 
native coronary arteries or coronary-artery grafts, and 
provided informed written consent. The study had a prag-
matic design, with few exclusion criteria.13 A total of 9013 
patients were included in NorStent, 54% of all Norwegian 
patients who underwent PCI during the study period. The 
response rate after three years was 82%.
Data collection
Clinical data were retrieved from the patients’ electronic med-
ical records by specially trained registered nurses. Self-
reported patient outcomes were measured three years after the 
PCI procedure using validated questionnaires14,15 as well as 
questions developed specifically for this study. Attendance in 
a CR programme was assessed by asking study participants 
the following questions representing two possible CR alterna-
tives: (a) Have you participated in a shorter ambulatory CR 
programme lasting for hours or days? (b) Have you partici-
pated in a hospital- or centre-based in-patient CR programme 
lasting for one or more weeks? The response options were 
‘yes’, ‘no’, or ‘uncertain’. The variable was coded as CR par-
ticipation if the patient answered ‘yes’ to one or both ques-
tions. ‘Uncertain’ and ‘no’ responses to both questions were 
coded as lack of CR participation. A study coordinating centre 
at the Institute of Clinical Medicine, the Arctic University of 
Norway, administered the follow-up data collection. Patients 
were sent reminders by phone and letter to complete and 
return their questionnaires.
Ethical issues
The study conforms to the principles outlined in the 
Declaration of Helsinki.16 All patients gave written informed 
consent to participate in the study and were informed about 
the opportunity to withdraw consent at any time without giv-
ing a reason. Study participants received the same routine 
medical treatment regardless of whether they had not partici-
pated in the trial. The NorStent trial protocols were reviewed 
and approved by the National Committees for Research 
Ethics in Norway and by the Norwegian Social Science Data 
Services (NSD19480, PREKNORD40/2008), and the trial is 
registered at ClinicalTrial.gov (NCT00811772).
Statistical analysis and data management
Categorical data are presented as counts and percentages, 
and continuous data as means with standard deviations, or 
medians with interquartile ranges. All the data were 
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checked for outliers. Gender, living arrangement, educa-
tional level, smoking status, medical history, and clinical 
findings were similarly distributed among CR alternative 
one and two, allowing us to conduct pooled analyses of the 
two alternatives. Further, separate analyses for the two 
alternatives of CR showed no differences in predictors 
(results not published), justifying analysing both CR alter-
natives together. Differences at baseline were tested using 
Pearson chi-square or Fisher’s Exact test for categorical 
variables. For continuous variables, we used independent 
Student’s t test or Mann-Whitney U test.
Logistic regression analysis was used to identify predic-
tors of CR participation. The multivariable model was built 
using independent variables that had a statistically signifi-
cant (p≤0.05) univariable (unadjusted) association with CR 
participation (age, health authorities (HAs), living arrange-
ment, educational level, smoking status, MI, coronary artery 
bypass graft (CABG), body mass index (BMI), and indica-
tion for PCI) in addition to existing evidence indicating an 
association (gender). All significant two-way interactions 
were tested in the full multivariate model, and only HA×age 
remained significant. A p-value equal to or below 0.05 was 
considered statistically significant.
Data management and all the statistical analyses were 
performed using IBM SPSS Statistics for Windows, ver-
sion 23 (IBM Corporation, Armonk, New York, USA).
Results
Patient characteristics
After three years of the study, 7068 patients responded to the 
survey, and 27.6% reported having participated in a CR pro-
gramme (CR<1 week; 52%, CR≥1 week; 48%). Baseline 
characteristics of the cohort, according to CR participation, 
are presented in Table 1. Males comprised 75.3% of the 
group, and the mean age of all participants was 63.1 years. A 
total of 75.9% of participants lived with a partner, and 31.1% 
had more than 12 years of education. Daily smoking was 
reported by 34.4% of participants. A prior MI or a diagnosis 
of diabetes mellitus was reported by 9.4% and 11.3% of 
patients, respectively. An acute coronary syndrome was the 
indication for PCI among 69.8% of the patients (Table 1).
CR participants vs non-CR participants
Compared to non-CR participants, the typical CR partici-
pant was younger, had more than 12 years of education, 
was currently smoking, had less severe prior CHD, and to 
a larger extent had acute coronary syndrome as the indica-
tion for PCI (Table 1).
CR programme participation
CR participation rate differed among the four HAs in 
Norway: 20% reported CR participation in the North HA, 
21% in the West HA, and 31% in each of the Central and 
the South-East HAs.
The multivariate logistic regression analysis revealed 
that men had a 28% less probability of participating in a CR 
programme compared to women, and the odds of attending 
CR decreased with increasing age (p<0.001), with higher 
attained level of education (p<0.001), and higher BMI 
(p=0.009) (Table 2). Patients hospitalised with an acute 
coronary syndrome had higher odds for attending CR than 
patients hospitalised with stable angina (odds ratio (OR) 
3.21, 95% confidence interval (CI) 2.74–3.76). Having had 
a prior CABG decreased the odds for CR (p<0.001).
When stratified by HA, the regression model showed 
that chronological age was a predictor for non-participation 
in all HA regions, with decreasing odds of CR participation 
for those above 70 years of age of 0.54 in the Central HA, 
0.31 in the South-East HA, 0.24 in the West HA, and 0.18 in 
the North HA (p for the interaction term=0.001) when con-
trolling for the other significant factors. In the North and 
South-East HAs, women had a higher chance of participat-
ing in CR than men, but this difference was not significant 
(p interaction=0.16). In the North HA prior MI and in South-
East HA prior CABG were significant contributors to a 
reduced CR participation rate.
Discussion
The present study indicates that 28% of patients who under-
went first-time PCI in Norway during 2008–2011 partici-
pated in a CR programme. The typical participant in Norway 
was young, overweight, well-educated, and had suffered 
from an acute coronary event. These results differed some-
what depending on the geographical location of the patients.
CR participation rates vary among European coun-
tries,7,17 and a participation rate of 28% revealed in the pre-
sent study for Norwegian patients is consistent with previous 
results reported for patients being treated in other European 
countries.18–20 In addition, our findings reveal that geo-
graphical differences within Norway exist for participation 
rate, which varied from 20–31% depending on the HA. 
These differences may be due to differences in systemic bar-
riers across the different regions of Norway. The four 
regional HAs are financed separately, and differences in the 
economic support that CR programmes receive might affect 
the availability of these programmes in different regions. 
Differences in referral strategies across regions may also 
explain to some extent the differences in CR participation 
rate.21 Furthermore, accessibility, excessively long travel-
ling distances and transportation difficulties are factors 
proven to affect patient participation in CR programmes.22
Previous research has shown that women are less likely 
to participate in CR.20 It has been suggested that factors, 
such as transportation, comorbidities and family responsi-
bilities affect women disproportionately, which then serve 
as higher barriers for women to participation in CR pro-
grammes.23 Surprisingly, when other factors are controlled 
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for in regression models, we observed in the present study 
that women were more likely to participate in a CR pro-
gramme than men. One possible explanation for this 
apparent disparity with previous studies is that women 
tend to participate later in the disease trajectory than men,24 
and since the follow-up time in our study was relatively 
longer at three years, barriers to participating for women 
were eventually lowered. Furthermore, our adjusting for 
prior CHD might have excluded more men that previ-
ously had participated in a CR programme, effectively 
uncovering true participation rates for genders. Another 
explanation is that the women in our study may have been 
more aware of the importance of CR than men. Indeed, in 
the last decade, there has been an increasing focus interna-
tionally on women and cardiovascular health issues, espe-
cially with regard to strategies that promote guideline 
implementation in women. Such initiatives could have 
affected how the women in our study viewed CR, causing 
them to view it more positively and to recognise the impor-
tance of participating in it.










Age (years) ±SD 63.1 ±10.2 59.7 ±9.6 64.4 ±10.1 <0.001
Male gender, n (%) 5321 (75.3) 1473 (75.6) 3848 (75.2) 0.723
Living arrangement, n (%) Spouse/partner 5132 (75.9) 1447 (78.6) 3685 (74.9) 0.005
Educational level attained, n (%) ≤12 years 4683 (68.9) 1162 (61.6) 3521 (71.7) <0.001
 > 12 years 2112 (31.1) 725 (38.4) 1387 (28.3)  
Clinical characteristics
Smoking status, n (%) Never 1960 (30.3) 493 (28.7) 1527 (32.2) <0.001
 Former 2282 (35.3) 527 (30.7) 1755 (37.0)  
 Current 2226 (34.4) 699 (40.7) 1467 (30.9)  
BMI (kg/m2) mean±SD 27.1 ±4 27.4 ±4.1 26.9 ±3.4 <0.001
Medical history, n (%) Prior MI 664 (9.4) 120 (6.2) 544 (10.7) <0.001
 Diabetes mellitus 801 (11.3) 201 (10.3) 600 (11.7) 0.097
 Prior CABG surgery 443 (6.3) 54 (2.8) 389 (7.6) <0.001
 Prior stroke 260 (3.7) 50 (2.6) 210 (4.1) 0.002
 Prior lipid treatment 3872 (55.6) 972 (50.7) 2900 (57.5) <0.001
 Prior HT treatment 3003 (42.8) 709 (36.7) 2294 (45.1) <0.001
Troponin T before procedure (ng/l) Median (IQR) 21 (204) 39.5 (301) 16 (168) <0.001
Creatinine concentration (μmol) Median (IQR) 76 (21) 74 (21) 77 (21) <0.001
Left ventricle ejection fraction, n (%) >40% 2619 (93.1) 538 (89.4) 2081 (94.1) <0.001
 ≤40% 194 (6.9) 65 (10.6) 130 (5.9)  
BP systolic, mean±SD 135.1 ±23.8 132.1 ±24 136.2 ±23.6 <0.001
BP diastolic, mean±SD 76.8 ±13 77.5 ±13.4 76.5 ±12.8 0.003
Angiographic and procedural characteristics and outcome
Indication for PCI, n (%) Stable angina 2124 (30.2) 297 (15.3) 1827 (35.9) <0.001
 Unstable angina 875 (12.5) 206 (10.6) 669 (13.2)  
 NSTEMI 2183 (31.1) 665 (34.3) 1518 (29.8)  
 STEMI 1843 (26.2) 771 (39.8) 1072 (21.1)  
Multivessel disease, n (%) 2746 (38.9) 711 (36.5) 2035 (39.8) 0.012
Stent treatment, n (%) Drug-eluting stents 3549 (50.2) 980 (50.3) 2569 (50.2) 0.942
 Bare-metal stents 3519 (49.8) 969 (49.7) 2550 (49.8)  
Medication at discharge, n (%) Clopidogrel 7039 (99.7) 1938 (99.5) 5101 (99.8) 0.040
 Aspirin 7025 (99.5) 1942 (99.6) 5083 (99.4) 0.272
 Beta-blockers 5219 (74.4) 1544 (79.6) 3675 (72.5) <0.001
 ACE inhibitors 1637 (23.3) 491 (25.3) 1146 (22.6) 0.016
 A-II blockers 1288 (18.4) 307 (15.8) 981 (19.3) 0.001
 Warfarin 92 (1.5) 27 (1.6) 65 (1.4) 0.748
A-II: angiotensin II; ACE: angiotensin-converting enzyme; BMI: body mass index; BP: blood pressure; CABG: coronary artery bypass graft; HT: hyper-
tension; IQR: interquartile range; MI: myocardial infarction; NSTEMI: non ST-elevation myocardial infarction; PCI: percutaneous coronary interven-
tion; SD: standard deviation; STEMI: ST-elevation myocardial infarction.
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Results from the present study confirm previous results 
showing that CR participation rate declines with increas-
ing age.22 Several factors influence the low CR participa-
tion rate among the elderly: decreased odds of being 
referred, less likely to attend, comorbidities, poorer under-
standing of the benefit, inadequate transportation, and car-
egiver responsibilities at home.25 Regarding the regional 
differences in participation, we observed that the elderly 
living in the northern and western parts of Norway partici-
pate in CR the least. This may be due to both lower avail-
ability of CR and longer travelling distances to locations 
offering a CR programme in these regions.
Previous research shows that current smoking increases 
the chance a patient will be referred to CR, but it does not 
predict CR participation.26 After controlling for other fac-
tors, we confirmed these findings. The strong correlation 
between smoking and lower educational level can explain 
the lack of a significant association.26 Having knowledge of 
how CR benefits one’s cardiac health is another important 
factor affecting participation in a CR programme, and the 
present study confirmed that patients with a higher attained 
educational level are more likely to participate in CR.
The present study showed that patients who suffer from 
an acute coronary event are more likely to participate in 
CR. In Norway, the majority of patients who participate in 
CR are referred to CR by the physician when they are dis-
charged from hospital. Patients who are hospitalised for 
MI are more likely to receive information about the bene-
fits of participating in CR and more likely to be referred to 
CR than are elective PCI patients. Thus, because they 
receive more encouragement to participate, patients who 
suffer from an MI are more likely to participate in CR. 
Prior CR participation can explain why a patient with prior 
MI or CABG reports engaging in CR less often compared 
to those with newly diagnosed CHD.
Methodological issues
The main strength of this study is its large sample size, 
representing all HA regions in Norway, and its high 
response rate. Indeed, this study included more than 50% 
of all patients in Norway undergoing PCI during 2008–
2011, and had a response rate of 82%.
The major limitation of the study was the use of a self-
report assessment tool to determine CR participation. Since 
the follow-up time was relatively long at three years, there is 
a chance of recall bias with the self-report approach. However, 
research mitigating this possibility has shown that it is less 
common for a person to wrongly believe that they have par-
ticipated in CR than to remember an event that did not occur.27 
In addition, assessment of CR participation by self-report has 
been validated in a previous study, showing nearly perfect 
agreement between self-report and site-verified CR participa-
tion.28 Furthermore, we do not know the level of participation 
or the length and content of the different CR programmes. 
Finally, a limitation is lack of knowledge of referral rate that 
enables us to calculate adherence to CR.
Conclusions
The estimated CR participation rate in Norway is below 
30%. The typical CR participant in Norway is young, 
Table 2. Parameters of logistic regression model predicting cardiac rehabilitation participation (n=1949).
Unadjusted Adjusted
 OR 95% CI p-value OR 95% CI p-value
Male 1.02 0.91–1.15 0.723 0.72 0.62–0.83 <0.001
Age (years) ≤59 1 <0.001 1 <0.001
 60–69 0.57 0.51–0.64 0.64 0.56–0.73  
 ≥70 0.30 0.26–0.35 0.31 0.26–0.37  
Living arrangement Spouse/partner 1.24 1.08–1.42 0.002 1.06 0.91–1.25 0.442
Education level attained >12 years 1.58 1.42–1.77 <0.001 1.50 1.32–1.72 <0.001
Smoking status Never 1 <0.001 1 0.816
 Former 0.19 0.77–1.03 1.02 0.90–1.20  
 Current 1.36 1.19–1.56 0.97 0.83–1.14  
Prior MI/CABG Yes 0.51 0.42–0.63 <0.001 0.71 0.55–0.91 0.007
BMI >25 1.17 1.05–1.31 0.005 1.19 1.04–1.35 0.012
Indication for PCI Acute 3.10 2.71–3.55 <0.001 3.23 2.76–3.79 <0.001
Health authorities North 1 <0.001 1 <0.001
 Central 1.80 1.47–2.22 1.73 1.38–2.16  
 South-East 1.80 1.52–2.13 1.76 1.46–2.13  
 West 1.06 0.86–1.30 0.89 0.71–1.12  
BMI: body mass index; CABG: coronary artery bypass grafting; CI: confidence interval; MI: myocardial infarction; OR: odds ratio; PCI: percutaneous 
coronary intervention.
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overweight, well-educated, and has suffered from an acute 
coronary event. This is consistent with previous research 
findings. Our findings also point out that CR participation 
varies geographically. This indicates that there is a need in 
Norway to establish uniform national standards and guide-
lines for CR. More research is needed to determine CR 
referral and adherence rates.
Implications for practice
•• Despite the beneficial evidence, referral to, 
and participation in, cardiac rehabilitation 
programmes varies widely across Europe, 
and in Norway less than 30% of patients with 
established coronary heart disease participate 
in a cardiac rehabilitation programme.
•• In contrast to previous research, the present 
study suggest that women, are more likely than 
men to participate in cardiac rehabilitation.
•• Healthcare professionals play an important 
role in promoting secondary prevention to 
patients with established coronary heart dis-
ease, and further actions to increase cardiac 
rehabilitation participation are needed.
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Cardiac rehabilitation and symptoms
of anxiety and depression after
percutaneous coronary intervention
Siv JS Olsen1,2, Henrik Schirmer2,3,4, Tom Wilsgaard5,
Kaare H Bønaa5,6,7 and Tove A Hanssen2,8
Abstract
Background: Anxiety and depression are related to coronary heart disease, and psychological support is recommended
in cardiac rehabilitation.
Purpose: The aims of this study were: to compare the prevalence of anxiety and depression with respect to cardiac
rehabilitation participation among patients who have been treated with percutaneous coronary intervention; to examine
prevalence of anxiety and depression among percutaneous coronary intervention patients compared to the general popu-
lation; and to identify predictors of symptomatic anxiety and depression among percutaneous coronary intervention patients.
Methods: We included 9013 patients undergoing first-time percutaneous coronary intervention. Anxiety and depres-
sion were assessed using the Hospital Anxiety and Depression Scale in a representative sample of 775 patients at baseline
and after three years of follow-up, and in the entire cohort at three-year follow-up.
Results: Cardiac rehabilitation participants had more anxiety and depression than cardiac rehabilitation non-participants
at baseline, and both groups had a more anxiety than the general population. The levels of anxiety and depression fell
significantly during three years of follow-up, but the changes did not differ between cardiac rehabilitation participants and
cardiac rehabilitation non-participants. Three years after percutaneous coronary intervention the prevalence of anxiety
was 32% (p< 0.001), higher among cardiac rehabilitation participants compared to cardiac rehabilitation non-partici-
pants. Female gender and younger age were associated with anxiety, whereas older age, lower levels of education and
cardiovascular morbidity were associated with depression.
Conclusion: The levels of anxiety and depression were prevalent among percutaneous coronary intervention patients
and the levels were not affected by cardiac rehabilitation participation. Anxiety is prevalent among female and younger
patients, whereas depression is related to older age and cardiovascular co-morbidity.
Keywords
Psychological factors, Hospital Anxiety and Depression Scale, Norwegian Coronary Stent Trial, coronary heart disease,
secondary prevention
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Introduction
Psychological factors such as anxiety and depression
are predictors of a worse prognosis in patients with
coronary heart disease (CHD).1,2 The association
between CHD and psychological illness can be
explained by several mechanisms. In the behavioural
pathway, poor control of coronary risk factors due to
an unhealthy lifestyle and poor medication adherence
leads to a poorer prognosis. In the physiological path-
way, autonomic dysfunction, endothelial dysfunction,
and changes in platelet aggregation or inflammation
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processes increase the risk of myocardial ischaemia.3,4
Tawakol et al. recently found an association between
perceived stress, regional brain activity, and cardiovas-
cular disease, and this association was possibly
mediated by inflammatory mechanisms.5
The prevalence of anxiety among CHD patients is
reported to be 16%, which is higher than the prevalence
found in the general population.6 Approximately
15–20% of patients with CHD meet the criteria for
major depression, and even more are suggested to have
clinically relevant depression.2,7 Recently, the
EUROASPIRE IV survey reported that 39% of women
and 22%ofmenwith CHDhad symptoms of anxiety and
depression at 1.4 years after the index event and the
prevalence seem to differ between countries.8 In the gen-
eral population, the lifetime prevalence of major depres-
sive disorder is reported to be between 4% and 10%.9
Exercise-based cardiac rehabilitation (CR) has been
shown to reduce anxiety10 and depression,10,11 and psy-
chological support is thus recommended as a component
of CR.12 However, the scientific evidence for this recom-
mendation was recently challenged by a review that did
not find any effect on total mortality, need for revascu-
larization, or the risk of non-fatal myocardial infarction
of adding psychological interventions to traditional CR.13
However, cardiac mortality was reduced, and symptoms
of anxiety, depression and stress were improved.13
The predictors of symptomatic anxiety and depres-
sion in CHD patients are reported to include female
gender, low educational level and more sedentary life-
style.8 Anxiety was more prevalent in younger individ-
uals. Depression increased with advancing age and was
associated with current smoking, central obesity and
diabetes.8 Despite an increasing focus on psychocar-
diology in the past few decades, there is a need for
more knowledge on the symptoms of anxiety and
depression related to CR participation.
In the present study, we compared levels of anxiety
and depression among patients who did and did not par-
ticipate in a CR programme after percutaneous coronary
intervention (PCI). Next, we compared levels of anxiety
and depression in PCI patients with the levels in the gen-
eral population. Finally, we assessed predictors of symp-
tomatic anxiety and depression three years after PCI.
Methods
Setting and participants
This prospective observational study included patients
undergoing first-time PCI in Norway. Patients were
recruited from the Norwegian Coronary Stent Trial
(NorStent).14 NorStent was performed at all centres in
Norway that perform PCI, covering a total population
of more than five million inhabitants. NorStent was a
randomised controlled trial comparing the long-term clin-
ical effects of drug-eluting and bare-metal stents.14
Patients were included from September 2008–February
2011, and the median follow-up time was five years.
Patients at least 18 years old were included if they were
able to communicate in Norwegian, had a Norwegian
personal identification number, were receiving their first
PCI due to either stable angina or an acute coronary
syndrome, and provided informed written consent. The
study used a pragmatic study design with few exclusion
criteria.14 A total of 9013 patients were included in
NorStent, 72.5% of patients with protocol eligibility.
Data collection
Clinical data were retrieved at baseline (defined in this
study as the time of the index PCI) from the patients’
electronic medical records by specially trained registered
nurses. Patient-reported symptoms of anxiety and
depression were measured in a representative sample of
775 patients at baseline and after three years of follow-
up, and in the in the entire cohort after three years of
follow-up. After three years of follow-up, 7068 patients
(82%) responded to the survey.
A study-coordinating centre at the Institute of
Clinical Medicine, The Arctic University of Norway,
collected the follow-up data. Patients were sent remin-
ders by phone and letter to complete and return their
questionnaires.
Symptoms of anxiety and depression
Patient-reported symptoms of anxiety and depression
were measured using the Norwegian version of the
Hospital Anxiety and Depression Scale (HADS).15
The HADS consists of a seven-item subscale for anxiety
(HADS-A) and a seven-item subscale for depression
(HADS-D). All questions have a four-point response
option, ranging from no points for no symptoms to
three points for the maximum number of symptoms.
The scores on each subscale range from 0 to 21
points. Lower scores reflect a lower symptom presence.
The HADS has demonstrated good psychometric prop-
erties across various patient samples and settings.16,17
The Norwegian reference population
The Norwegian reference population comprised partici-
pants in the second wave of a large population-based gen-
eral health survey, the 1995–1997 Nord-Trøndelag Health
study (The HUNT 2 study). A total of 66,140 individuals
participated in the study, and 71% of those invited were in
the 20-year-old age group.18 The present study com-
pared the results of the HADS among PCI patients with
the results from 54,867 subjects without previous
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self-reported cardiovascular disease. In both the HUNT
study and the present study, the HADS was assessed by
self-report using mailed questionnaires.
Cardiac rehabilitation
Attendance in a CR programme during follow-up was
assessed after three years of follow-up by asking study
participants the following questions, which assessed
two possible CR alternatives: (a) Have you participated
in a shorter ambulatory CR programme lasting for
hours or days? (b) Have you participated in a hospital-
or centre-based in-patient CR programme lasting one
or more weeks? The response options were ‘yes’, ‘no’,
or ‘uncertain’. The variable was coded as CR partici-
pation if the patient answered ‘yes’ to one or both ques-
tions. Responses of ‘uncertain’ and ‘no’ to both
questions were coded as CR non-participation.
Ethical issues
The study conforms to the principles outlined in the
Declaration of Helsinki.19 All patients provided written
informed consent to participate in the study and were
informed about the opportunity to withdraw consent
at any time without stating a reason. Study partici-
pants received the same routine medical treatment
as non-participants. The NorStent trial protocols
were reviewed and approved by the National
Committees for Research Ethics in Norway and by
the Norwegian Social Science Data Services
(NSD19480, PREKNORD40/2008), and they are regis-
tered at ClinicalTrials.gov (NCT00811772).
Statistical analysis and data management
Categorical data are presented as counts and percent-
ages, and continuous data are presented as means with
standard deviations (SDs) or medians with inter-
quartile ranges. All variables were checked for outliers.
Differences in baseline characteristics were assessed
using Pearson’s chi-square or independent samples
Student’s t-test, as appropriate. A p-value 0.05 was
considered statistically significant. Data management
and all statistical analyses were performed using IBM
SPSS Statistics for Windows, versions 23 and 24 (IBM
Corporation, Armonk, New York).
Between-group comparisons in HADS scores were
performed using the independent samples t-test, and
within-group comparisons were performed using
paired sample t-tests. Less than 2.5% of the items in
the HADS had one or more missing responses. Simple
mean imputation20 was performed when the respondent
had answered at least four of the seven items in each
subscale. A cut-off score of eight on the subscales has
been found to provide an optimal balance between sen-
sitivity and specificity for identifying possible or prob-
able cases of anxiety or depressive disorder,16 with
scores <8 representing no symptoms of anxiety or
depression.15 The internal consistency (Cronbach’s
alpha) was 0.86 for the HADS-A and 0.80 for the
HADS-D at baseline and 0.88 for the HADS-A and
0.84 for the HADS-D at the three-year follow-up.
To adjust for the effect of non-random distribution of
covariates, a propensity score (PS) method was used for
comparisons of anxiety and depression after three years
of follow-up among CR participants and non-partici-
pants.21 In the present study, the PS was calculated for
each patient using a logistic regression model to estimate
the probability of participating in CR. The variables
included in this model were age, gender, educational
level, smoking status, body mass index (BMI), prior
myocardial infarction (MI), diabetes mellitus, prior
coronary artery bypass surgery, prior stroke,
prior lipid-lowering treatment, prior hypertension treat-
ment, creatinine concentration, left ventricle ejection
fraction, health authority and indication for PCI. Once
the PSs were estimated for each patient, matching was
performed using a match tolerance level of 0.02.
Covariate balance was checked as recommended for stu-
dies reporting PS analysis.22
The expected HADS-A and HADS-D scores in the
general population were calculated using previously
developed formulas based on the Norwegian general
population, controlling for each participants age,
gender, educational level and smoking habit.23
Differences between the observed score in the study
population scores and the expected scores in the general
population were analysed using the one-sample t-test.
Logistic regression analysis was used to identify pre-
dictors of symptomatic anxiety and depression. The
multivariable model was built using independent vari-
ables associated with anxiety and depression;4 severity
of CHD,24 gender, age, living arrangement, educational
level attained, smoking status, BMI, prior MI/coronary
artery bypass grafting (CABG), prior stroke, prior dia-
betes mellitus, prior lipid-lowering treatment, prior
hypertension treatment, left ventricular ejection frac-
tion, PCI indication and CR. Two-way interactions
between the independent variables and gender, age
and CR were assessed in the full multivariable model.
Results
Baseline characteristics
After three years in the study, 7068 patients responded to
the survey. Of these patients, a subgroup (n¼ 941) had
also been invited to report symptoms of anxiety and
depression at baseline, with a response rate of 82.4%
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(n¼ 775). The subgroup population was similar to the
rest of the cohort for most of the clinical characteristics,
except for PCI indication (see the Supplementary
Material Appendix Table 1). Table 1 shows the baseline
characteristics of the subgroup stratified by CR partici-
pation. Compared with the CR participants, the CR non-
participants were older, had a lower level of education,
were less likely to smoke, had a higher degree of comor-
bidity and were less likely to have acute MI as an indica-
tion for PCI. Twenty-seven per cent of patients had
a HADS anxiety score 8, and 19% of patients had
a HADS depression score 8 at the time of PCI.
CR and symptoms of anxiety and depression
at baseline and after three years
Table 2 shows the scores for anxiety and depression
according to participation in CR for the subgroup
with HADS scores both at baseline and after three
years. Compared to non-participants, CR participants
had significantly higher anxiety and depression scores
at both baseline and the three-year follow-up. Levels of
anxiety and depression fell significantly (p< 0.001) in
both groups during the follow-up, but the changes
over time did not differ between those who did and
did not participate in CR (Table 2).
Table 3 shows prevalence of anxiety and depression
after three years of follow-up according to CR par-
ticipation in a propensity-matched cohort represent-
ing 3402 patients with available HADS scores.
The covariate balance is shown in Supplementary
Material Appendix Table 2. After three years of
follow-up, there was a 32% higher prevalence of
anxiety (p¼ 0.003) among CR participants than non-
participants, whereas prevalence of depression did not
differ.
Table 1. Baseline characteristics according to cardiac rehabilitation participation.a
All Cardiac rehabilitation
Characteristics (n¼ 775) Yes (n¼ 183) No (n¼ 592) p-Value
Age Years SD 64.0 9.2 60.1 8.1 65.3 9.2 <0.001
Gender – n (%) Male 583 (75.2) 142 (77.6) 441 (74.5) 0.396
Living arrangement – n (%) Spouse/partner 591 (79.6) 139 (83.2) 452 (78.6) 0.191
Educational level attained – n (%) 12 years 495 (66.7) 105 (59.3) 390 (69.0) 0.017
>12 years 247 (33.3) 72 (40.7) 175 (31.0)
Smoking status – n (%) Never 235 (31.3) 61 (34.7) 174 (30.3) 0.018
Former 319 (42.5) 59 (33.5) 260 (45.3)
Current 196 (26.1) 56 (31.8) 104 (24.4)
Body mass index (kg/m2) >25 kg/m2 529 (68.3) 131 (71.6) 398 (67.2) 0.269
Medical history – n (%) Prior myocardial infarction 76 (9.8) 14 (7.7) 62 (10.5) 0.259
Diabetes mellitus 98 (12.7) 23 (12.6) 75 (12.7) 0.991
Prior CABG surgery 58 (7.5) 7 (3.8) 51 (8.6) 0.031
Prior stroke 27 (3.5) 2 (1.1) 25 (4.2) 0.044
Prior lipid lowering treatment 459 (59.8) 93 (51.7) 366 (62.4) 0.011
Prior HT treatment 321 (41.7) 66 (36.7) 255 (43.2) 0.119
Left ventricular ejection
fraction – n (%)
>40% 282 (95.6) 60 (92.3) 222 (96.5) 0.144
40% 13 (4.4) 8 (3.5) 5 (7.7)
Indication for PCI – n (%) Stable angina 330 (39.8) 39 (21.4) 268 (45.5) <0.001
Unstable angina 98 (12.6) 15 (8.2) 83 (14.1)
NSTEMI 218 (28.3) 68 (37.4) 150 (25.5)
STEMI 148 (19.2) 60 (33.0) 88 (14.9)
HADS-anxiety score 8, n (%) 210 (27.1) 68 (37.2) 142 (24.0) <0.001
HADS-depression score 8, n (%) 147 (19.0) 50 (27.3) 97 (16.4) 0.001
CABG: coronary artery bypass graft; HADS: Hospital Anxiety and Depression Scale; HT: hypertension; PCI: percutaneous coronary intervention;
NSTEMI: non ST-elevation myocardial infarction; SD: standard deviation; STEMI: ST-elevation myocardial infarction.
Values are the mean (SD) or n (%).
aThis analysis includes 775 patients who were examined using the Hospital Anxiety and Depression Scale at both baseline (i.e. the time of the index
PCI) and the three-year follow-up.
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Symptoms of anxiety and depression in PCI patients
compared to the reference population
Table 2 shows observed and expected scores for anxiety
and depression in the subgroup of patients with HADS
measurements at baseline and after three years of
follow-up. At baseline, the patients had significantly
higher levels of anxiety than the reference population
(Table 2). After three years of follow-up, the level of
anxiety continued to be higher than expected among
CR participants, but not among CR non-participants.
At baseline the depression levels were higher than
expected among CR participants but not among CR
non-participants (Table 2). After three years of
follow-up, depression levels did not differ among CR
participants compared to the expected levels, whereas
CR non-participants had lower depression levels than
expected.
In a separate analysis of the total cohort of 7068
patients the HADS-A score after three years of
follow-up was significantly higher than that in the ref-
erence population (3.92 (SD: 3.63) vs 3.44 (SD:
0.45), p< 0.001), while the HADS-D score after
three years of follow-up was significantly lower than
in the reference population (3.42 (SD: 3.44) vs 3.85
(SD: 0.48), p< 0.001).
Predictors of symptomatic anxiety and depression
Multivariable-adjusted analyses showed that male
gender and older age were associated with lower risk
of anxiety, whereas CR participation was associated
with higher risk of anxiety (Table 4). Higher levels of
education and an acute coronary event as the indication
for PCI were associated with lower risk of depression,
whereas older age, former smoking, prior myocardial
infarction, CABG and stroke were associated with
higher risk of depression (Table 4).
Discussion
We found that 27% and 19% of patients undergoing
PCI reported symptoms of anxiety and depression,
respectively, with the highest levels found in the CR
Table 2. Changes in symptoms of anxiety and depression during follow-up according to cardiac rehabilitation participation.a
Cardiac rehabilitation
Yes (n¼ 183) No (n¼ 592)
Observed Expected Observed Expected p-Valueb
HADS-anxiety score, mean SD
Baseline 6.31 4.33 3.50 0.50c 5.04 4.03 3.49 0.46c <0.001
3 Years 4.52 4.14 3.40 0.44c 3.52 3.50 3.42 0.45 0.001
Change –1.79 4.23d –1.53 3.47y 0.396
HADS-depression score, mean SD
Baseline 4.69 4.10 3.59 0.42c 3.84 3.45 3.84 0.44 0.005
3 Years 3.78 4.09 3.67 0.41 3.08 3.33 3.94 0.46c 0.019
Change –0.91 4.05d –0.76 3.33d 0.607
HADS: Hospital Anxiety and Depression Scale; PCI: percutaneous coronary intervention; SD: standard deviation.
aThis analysis includes 775 patients who were examined with the HADS at both baseline (i.e. the time of the index PCI) and the three-year follow-up.
bValues of p indicate differences between patients who did and did not undergo cardiac rehabilitation.
cp 0.001. Values of p indicate differences between observed and expected HADS scores
dThe change represent a significant reduction (p< 0.001) from baseline to three-year follow-up.
Table 3. Symptoms of anxiety and depression (Hospital Anxiety and Depression Scale (HADS) 8) in cardiac




(n¼ 1697) OR (95% CI) p-Value
HADS-anxiety score 8 320 (18.8%) 254 (15.0%) 1.32 (1.10–1.58) 0.003
HADS-depression score 8 239 (14.1%) 214 (12.6%) 1.14 (0.93–1.39) 0.207
CI: confidence interval; OR: odds ratio.
aThis table shows the results for the propensity-matched cohort (n¼ 3402).
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participants. There were no differences in the change in
symptoms of anxiety and depression between the CR
participants and CR non-participants. After three
years, both the CR participants and CR non-partici-
pants had a higher level of anxiety, but not depression,
than the reference population. Female gender and
young age are associated with anxiety, while older
age, lower-education and previous cardiovascular mor-
bidity are associated with depression.
The present study revealed a higher prevalence of
symptomatic anxiety6,23 and depression8,23 at the
index event than reported in previous studies in CHD
patients from Nordic countries. This prevalence was
consistent with the mean results in Europe8 and lower
than that reported in a PCI population.25 After three
years, both the CR participants and CR non-partici-
pants had a higher level of anxiety but lower level of
depression than expected, indicating that symptoms of
anxiety are a long-term concern after PCI, while the
level of depression normalises.
Fear is the essence of anxiety and is often used as a
motivator for people in need of reducing risky behav-
iours.26 Fear increases the chance of one-time behav-
iours26 and can explain why the present study shows
that more anxious patients reported having partici-
pated in CR programmes. Variation in anxiety over a
lifetime is normal; however, the present study revealed
that CR participants reported a higher level of anxiety
at three years of follow-up compared with the reference
population. These findings indicate that some of the
CR participants had a generalised anxiety disorder
with more persistent symptoms.
It has previously been suggested that psychological
screening and management of psychological disorder in
CHD patients are well suited in the CR context.27
However, the CR participation rate is generally
reported to be low.28 Depressed patients are also
reported to be at a higher risk of not participating, as
well as dropping out of CR.29 This result is in contrast
to our findings, which show that CR participants report
higher depression scores than CR non-participants.
Similar findings were reported in a retrospective study
of 158,991 post-MI patients, in whom depression was
strongly associated with CR attendance.30 Overall, the
present study suggests that the patients most in need,
i.e. those with the highest level of symptoms of anxiety
and depression, are identified and encouraged to par-
ticipate in CR programmes in Norway.
The present study did not identify any changes in
symptoms of anxiety and depression between the CR
participants and CR non-participants. However, there
were significant improvements over time in both
groups. It has previously been suggested that the posi-
tive correlation between CR and improvement in anx-
iety and depression is related to the positive effect of
exercising,10,31 especially in women.32 However, a
Cochrane review reported only a small effect of exercise
on the reduction of symptoms of depression compared
to a control intervention when analysing studies of
methodological robustness.33 In Norway, however,
there is no standard regarding the content of physical
activity in CR programmes, which can vary from a
single day of exercise for one hour to exercise training
over several weeks. Consequently, this may be a pos-
sible reason for the lack of effect in the present study. In
addition, the level of psychological intervention during
CR in Norway is not standardised. However, this lack
of standardization may be of less importance, as the
effect of psychological interventions on anxiety and
depression has a low level of evidence.13 Overall, des-
pite a reduction in the level of symptoms of anxiety and
depression after three years, the present study did not
identify a beneficial effect of CR participation.
CHD patients with symptoms of anxiety and depres-
sion are known to have a poorer cardiac health prog-
nosis, which in turn makes it necessary to ensure that
psychological treatments reach patients in need. The
recommendation of systematic screening for anxiety
and depression in CHD patients is disputed.34,35
However, knowledge regarding the predictors of
future symptomatic anxiety or depression can help to
target the treatment. Regarding anxiety, the present
study showed that women are at risk of reporting
symptomatic anxiety. The gender difference corres-
ponds to findings from the general population36 and
the EUROSPIRE IV study, which includes CHD
patients.8 Pogosova et al. also reported similar findings
for age.8 The present study suggests that less-educated
older patients with cardiovascular diseases, a history of
smoking and acute coronary syndrome are at risk of
symptoms of depression. The EUROSPIRE IV study
yielded similar results in terms of educational level and
age. Overall, the present study suggests that healthcare
providers should pay attention to younger patients and
women to prevent long-term symptoms of anxiety and
to older, comorbid and less-educated patients to pre-
vent long-term symptoms of depression after PCI.
Methodological issues
One limitation of the present study is the inability to
control for factors, such as previously diagnosed anx-
iety and depression disorders and treatment with anti-
depressants. Furthermore, not knowing the content
and level of CR, especially physical activity and psy-
chological support, may have influenced our findings.
However, the major strengths of the study are the large
representative sample, the prospective design, the high
response rate and long-term follow-up, as well as the
use of a standardised and validated instrument. In
Olsen et al. 7
contrast to diagnostic interviews and other self-
reported instruments, the HADS systematically
excludes somatic symptoms that can be mistaken as
heart disease.15 Furthermore, the PS matching
method allows for the control of several possible con-
founding factors when analysing the effect of CR on
symptoms of anxiety and depression.
Conclusions
In conclusion, the present study suggests that every
fourth or fifth patient will report symptoms of anxiety
or depression at the index event. However, three years
after PCI, fewer patients reported symptoms of anxiety
or depression and the level of depression was lower
than expected in these patients compared to the refer-
ence population. Furthermore, the present study sug-
gests that patients participating in a CR programme are
those with the highest level of symptoms of anxiety and
depression. Despite the decreased level of anxiety and
depression after three years, the present study did not
identify a beneficial effect of CR participation. Finally,
the present study reports several patient characteristics
that are related to future risk of long-term symptoms of
anxiety and depression after PCI.
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Background: Vocational support is recommended for patients in cardiac rehabilitation (CR), 
as returning to work is important in patients’ social readjusting after an acute coronary event. 
Information is lacking whether CR leads to higher long-term employment after percutaneous 
coronary intervention (PCI). 
Aims: The aims of this study were to determine employment status three years after 
percutaneous coronary intervention, to compare employment status between CR participants 
and CR non-participants and to assess predictors for employment. 
Methods: We included first-time PCI patients from the NorStent trial, who were of working 
age (<63 years; n=2488) at a three-year follow-up. Employment status and CR participation 
were assessed using a self-report questionnaire. Propensity score method was used in 
comparing employment status of CR participants and CR non-participants.  
Results: Seventy per cent of participants who were <60 years of age at the index event were 
employed at follow-up and CR participation had no effect on employment status. Being male, 
living with a partner, and attaining higher levels of education were associated with a higher 
chance of being employed, while being older, prior cardiovascular morbidity, and smoking 
status were associated with lower chance of being employed at follow-up. 
Conclusion: Because a significant number of working-age coronary heart disease patients are 
unemployed three years after coronary revascularization, updated incentives should be 
implemented to promote vocational support. Such programmes should focus on females, 








Cardiac rehabilitation (CR) is a recommended aftercare for patients with established coronary 
heart disease (CHD).1, 2 Return to work was one of the main outcomes in the early eras of CR 
and vocational support is still an important aspect of contemporary CR. Additionally, risk-
factor management, exercise training, nutritional counselling, and psychosocial support are 
integral parts of CR.3, 4 Systematic reviews indicate that CR may reduce cardiac mortality, 
hospital admissions, symptoms of anxiety and depression, and increase the quality of life, 
although there is no strong evidence of these benefits.5-7 Recently, a Cochrane review that 
examined interventions to support return to work for people with CHD concluded, with a low-
certainty of evidence, that comprehensive CR may promote return to work within the first six 
months following CHD. There were little to no evidence that CR promote return to work 
between six months and up to one year after a CHD event, and no evidence that CR promote 
return to work after one year of follow up.8 Despite that return to work plays an important part 
in social readjustment after an acute coronary event, and has important implications for both 
the individual and the society, the knowledge on long-term effect of CR on employment 
status is scarce.8 In addition, knowledge on predictors of employment are of importance to 
decrease the risk of reintegration failure after an acute coronary syndrome.9  
In the present study, we determined employment status three years after percutaneous 
coronary intervention (PCI). Next, we compared differences between CR participants and CR 
non-participants in employment status three years after PCI. Finally, we assessed predictors 





Setting and participants 
The present study uses a prospective observational study design among patients that 
underwent first time PCI and were participating in the Norwegian Coronary Stent Trial 
(NorStent).10 NorStent was an all-comer study with broad inclusion criteria and few exclusion 
criteria which was performed at all centres in Norway that perform PCI, thus covering the 
total Norwegian population of more than 5 million inhabitants. NorStent was a randomized 
controlled trial comparing long-term health effects of drug-eluting and bare-metal stents.10 
Participants were included from September 2008 to February 2011 with five years follow-up. 
Eligible participants were men and women who presented with stable angina or an acute 
coronary syndrome, had a lesion in native coronary arteries or coronary-artery grafts 
amenable for PCI, had a Norwegian national identification number and were able to 
communicate in Norwegian, and provided informed consent. A total of 9,013 participants 
were included in NorStent. After three years of follow-up, 7,068 patients (82%) responded to 
a postal survey which included questions on employment status. Baseline characteristics have 
been reported previously.11 To avoid patients that became unemployed due to retirement, we 
excluded patients from analysis who were 60 years and older at the index event. A total of 
2,488 patients with complete employment status data three years after PCI were accepted for 
inclusion in the present study. 
Data collection 
Clinical- and demographic data were retrieved from the patients’ electronic medical records at 
the index event by specially trained registered nurses. Patient outcomes, including CR 
participation, were measured three years after the PCI procedure using validated 




centre at the Institute of Clinical Medicine, the Arctic University of Norway, administrated 
the collection of follow-up data. Patients were sent reminders by phone and postal letter to 
complete and return their questionnaires.  
Cardiac rehabilitation 
Attendance in a CR programme during the period from the index event and to 36 months, was 
assessed by asking study participants the following questions: (1) Have you participated in a 
shorter ambulatory CR programme lasting for hours or days? (2) Have you participated in a 
hospital- or centre-based in-patient CR programme lasting for one or more weeks? The 
response options were ‘yes’, ‘no’, or ‘uncertain’.CR attendance was coded as “yes” if the 
patient answered ‘yes’ to one or both questions, and “no” if the patient answered ‘uncertain’ 
or ‘no’ to both questions.  
Employment status  
Employment status 36 months after the index event were ascertained by asking the study 
participants if they were currently employed full-time or part-time, unemployed, retired on 
disability pension, or on sick leave full-time or part-time, or if they were homemakers.  
Employment status was categorised as ‘employed’, ‘unemployed’ or ‘retired’. Being 
employed was classified as employed full-time or part-time. Being unemployed was classified 
as unemployed or sick-leave full-time or part-time. Being retired was participants that 
reported to receive full-time or disability pension. The combinations part-time employed / 






Ethical issues  
The study conformed to the principles outlined in the Declaration of Helsinki.12 All 
participants gave written informed consent to participate in the study and were informed 
about the opportunity to withdraw the consent at any time without giving a reason or 
prejudice regarding further treatment. Study participants received routine medical treatment 
after PCI. The NorStent trial protocols were reviewed and approved by the National 
Committees for Research Ethics in Norway and by the Norwegian Social Science Data 
Services (NSD19480, PREKNORD40/2008), and is registered in ClinicalTrial.gov 
(NCT00811772). 
Statistical analysis  
Categorical data are presented as counts and percentages, and continuous data as means with 
standard deviations. To adjust for the effect of non-random distribution of covariates on CR, a 
propensity score method was used for comparisons of employment status after 3 years of 
follow-up among CR participants and non-participants.13 In the present study, the propensity 
score was calculated for each patient in the total cohort of 2,488 patients using a logistic 
regression model to estimate the probability of participating in CR. The variables included in 
this model were age, gender, educational level, smoking status, body mass index (BMI), prior 
myocardial infarction (MI) or coronary artery bypass graft, diabetes mellitus, prior lipid-
lowering treatment, prior hypertension treatment, regional health authority and indication for 
PCI. Once the propensity scores were estimated for each patient, matching was performed 
using a match tolerance level of 0.02. This leaves us with 708 patients in each group (CR yes 
vs. CR no). Covariate balance was checked as recommended for studies reporting propensity 
score analyses14 Between-group comparisons in employment status were performed using 




Logistic regression analysis was used to identify predictors of being employed three years 
after PCI. Possible predictors were independent variables known to be associated with 
severity of CHD1 and geographical region; gender, age, living arrangement, educational level 
attained, smoking status, BMI, prior MI or coronary artery bypass grafting, prior stroke, prior 
diabetes mellitus, prior lipid-lowering treatment, prior hypertension treatment, left ventricular 
ejection fraction, PCI indication, CR, and regional health authority. Unadjusted and 
multivariable adjusted odds ratios (OR) of employment status were estimated with 95% 
confidence intervals (CI). The multivariable model included all independent variables. Due to 
missing values on some of the independent variables, the unadjusted odds ratios were 
calculated both with all available observations included and restricted to completed case 
analyses (n=2038). Two-way interactions between the independent variables and gender and 
age were assessed in the full multivariable model. A p-value of <0.05 was considered 
statistically significant. Data were organized in IBM SPSS data files, and statistical analyses 
were performed using IBM SPSS Statistics for Windows, version 25 (IBM Corporation, 












Of the 9,013 patients who were enrolled in the NorStent trial, 2,488 were of working age (<63 
years) three years following PCI. Males compromise 83.2% of the group, and the mean age 
was 52 years. The majority of the participants lived with a partner, 36.5% had more than 12 
years of education and approximately half of the participants were current smokers. Prior 
lipid-lowering treatment and prior hypertension treatment were reported by 51.1% and 34.0% 
of the participants, respectively. An acute coronary syndrome was the indication for PCI 
among 63.7% of the participants (Table 1). 
Employment status and Cardiac rehabilitation 
After three years follow-up, the majority of the participants were employed, while 11.2% 
were unemployed and 18.6% were retired (Table 1). A total of 38.3% of the patients reported 
to have participated in a CR programme at some point during the period from baseline to 36 
months (Table 1).  
Table 2 shows employment status according to participation in CR in a propensity-matched 
cohort representing 1416 patients. The covariate balance is shown in Supplementary Material 
Appendix Table 1. In the propensity-matched cohort, employment status of participants who 
were in a CR programme did not differ from those who were not in a CR programme 
(p=0.580). 
Predictors of being employed three years after PCI 
The multivariable-adjusted analyses showed that male participants, participants living with a 
partner, and participants with a higher level of education had a significantly higher chance of 




of Norway had a greater chance of being employed compared to participants in the northern 
part of Norway (Table 3). Higher age, former smoking, prior myocardial infarction or 
coronary artery bypass grafting, and prior hypertension treatment were associated with lower 









In the present study we assessed participant employment status three years after PCI and 
whether CR participation and other demographic and clinical factors predict employment 
status. We found that 70% of participants 62 years and younger reported to be employed three 
years after PCI. A total of 38% of the participants reported to have participated in a CR 
programme. There were no differences in long-term employment status between CR 
participants and CR non-participants. Male gender, living with a partner and higher levels of 
education are associated with higher chance of being employed, while older age, previous 
cardiovascular morbidity, prior hypertension treatment and smoking status are associated with 
lower chance of being employed three years after PCI. 
Differences between prior studies and the present study population, severity of the coronary 
disease, state of employment at inclusion and follow-up time make it difficult to compare our 
findings on employment status with previous studies. The present study showed that 70% of 
patients 62 years and younger reported to be employed three years after PCI. This percentage 
is only slightly lower than that for the general population in Norway aged 25 to 66 years old, 
79% of which were employed during 2018.15 In previous international studies of employed 
patients, 86-93% of the patients were found to have returned to work one year after acute 
MI.16-19 However, detachment is present, in a Danish nationwide register-based study almost a 
quarter of MI patients reported to quit working one year after they successfully returned to 
work.17 This demonstrates the importance of long-term follow-up when measuring return-to-
work rates after cardiovascular revascularization. A population based Danish study including 
21,926 patients, showed that five years after the first-time hospitalization for acute coronary 
syndrome, 88% were still a part of the workforce where 65% were in work, 19% were 




When it comes to retirement at an early age, a nationwide cohort study from Sweden found 
that approximately one-third of patients were granted disability pension within five years after 
CABG or PCI.21 In the present study, about 19% of patients 62 years and younger, reported to 
be retired three years after PCI demonstrating that approximately twice as many patients 
suffering from CHD leaves the workforce in an early age compared to the general 
population.15 A history of long-term sickness absence prior to revascularization is a strong 
predictor for long-term sickness absence following PCI, followed by disability pension.21, 22 
In addition, disability pension at the time of coronary revascularization is associated with 
higher five-year mortality.23 Taken together, these findings indicate that employment status is 
an important component of secondary prevention after a first-time PCI. The aim of CR is to 
improve later working capacity in younger patients and to prevent premature death. 
Information about the effects of CR on return to work is scarce, and of the relevant studies, 
findings are inconsistent. The present study reveals, as shown previously in the same 
population,11 that patients in working age in a higher degree participate in a CR programme 
compared to older patients. This is consistent with previous findings.24, 25 Notably, CR 
participation can contribute to a delayed return to work.26 Our propensity-matched 
comparison of patient employment status three years after PCI showed that employment 
status of those participating in CR did not significantly differ from those who did not 
participate in CR. However, since the employment status of our participants before the index 
event was unknown, we could not confidently determine whether changes in employment 
status could be related to CR participation or not. Moreover, at the time of our study, no 
national or international standard on return to work in CR programmes existed.27 Thus, we 




study is an important contribution as todays’ knowledge on the long-term effect of CR on 
employment status is scarce, of old age and inconclusive.8  
A recently published guideline on reintegration strategies to promote optimal return to work 
in acute coronary syndrome patients recommend early identification of patients at risk of poor 
vocational outcome.9 Knowing the predictors of future employment status can help to 
facilitate vocational reintegration for patients in need. The present study found that being 
male, living with a partner, and higher levels of educational attainment were associated with a 
greater chance of being employed three years after PCI. This is consistent with previous 
findings showing a beneficial association between educational level16-18, 20 and living with a 
partner16, 20 with return to work. Regarding gender differences, what we observed was 
consistent with the majority of previous findings, suggesting that women have lower rates of 
returning to work and longer sickness absences than men.17, 20, 22 Dreyer et al. and Cauter et al, 
however, did not find gender differences in their study after adjustment for other 
characteristics.16, 26 
The present study suggests that the chance of being employed decreases with age and 
previous cardiovascular morbidity. One possible explanation is that in Norway, disability 
pension could be granted to people with long-term work incapacity. In an early age, retraining 
for patients with blue collar work is an opportunity, but a less relevant option for patients that 
are to be granted old-age pension in near future. In addition, having a manual job has 
previously been associated with delayed return to work26. Patients reported to live in the 
Northern part of Norway have a higher chance of being unemployed in the present study. 
Fewer opportunities for retraining or changing type of job in the rural areas of Norway can be 




were associated with lower chance of being employed three years after PCI, corresponding to 
prior research findings.19 Overall, healthcare providers should pay attention to factors that are 
associated with unemployment in patients undergoing PCI to prevent future poor vocational 
outcome. 
Methodological issues 
The present study had many strengths, such as a large representative sample with, inclusion of 
only patients who were of working age, a prospective study design, long-term follow-up, and 
high response rate. Despite these strengths, there were some limitations. Firstly, we had no 
data on the participants’ employment status at the index event, the participants’ job 
satisfaction, and whether the participants had worked in white- or blue-collar jobs. Those 
kinds of data could have had an impact on their employment status at the 36-month follow-
up. Secondly, as this was a prospective observational study, it could be susceptible to bias. To 
reduce bias, however, and control for several possible confounding factors when analysing the 
effect of CR on employment status, we performed propensity score matching.  
Conclusions 
Despite improvements in the prognosis for CHD patients, the present study suggests that a 
significant number of working-age patients remain unemployed three years after their first 
coronary revascularization. These individuals’ employment status was not aided by CR 
participation. Focusing more vocational support on PCI patients who are older, lacking higher 
education and patients who are living alone may improve return to work, probability of 
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Table 1. Baseline characteristics of participants at index event and employment status at 
3 years of follow-up. 
Characteristic (n=2488) 
Age  (years ± SD) 52 ± 5.5 
Male gender, n (%) 2071 (83.2) 
Living with a spouse/partner, n (%)  1953 (84.4) 
Educational level ≤12 years, n (%) 1511 (63.5) 
Current smoker, n (%) 1137 (48.9) 
Body mass index (kg/m2)   
>25 kg/m2 1782 (71.6) 
Medical history, n (%)  
Prior myocardial infarction 125 (5.0) 
Diabetes mellitus 242 (9.8) 
Prior CABG surgery 51 (2.0) 
Prior stroke 42 (1.7) 
Prior lipid-lowering treatment 1256 (51.1) 
Prior HT treatment 840 (34.0) 
Left ventricular ejection fraction, n (%)  
>40% 897 (94.7) 
Indication for PCI, n (%)  
Stable angina 586 (23.7) 
Acute coronary syndrome 1889 (76.3) 
3-year follow-up  
Employment status, n (%)  
Unemployed 278 (11.2) 
Employed 1747 (70.2) 
Retired  463 (18.6) 
CR participation 
 
Yes 953 (38.3) 
Values are means (SD) or n (%). 
SD: standard deviation; CR: cardiac rehabilitation; CABG: coronary artery bypass graft; 





Table 2. Differences in employment status between CR participants and CR non-participants three years 
after percutaneous coronary interventiona 
  CR participants (n=708) CR non-participants (n=708) p-valueb 
Unemployed 85 (10.2) 77 (10.9) 0.580 
Employed 499 (70.5) 494 (69.8) — 
Retired 124 (17.5) 137 (19.4) — 
Values are n (%). 
aTable shows results for the propensity-matched cohort (n=1416). 
b Between-group comparisons in employment status were performed using conditional logistic regression 









Table 3. Odds ratios for being employed three years after percutaneous coronary interventiona 
Unemployedb (reference) vs. employed  Unadjusted   Adjusted  
  
 
OR 95% CI P-
value 
 OR 95% CI p-value 
Male (female = reference) 
 
1.94 1.53 - 2.50 <0.001  1.93 1.50 - 2.50 <0.001 
Age (years) 
    
 
   
<50 (reference) 1 
 





0.62 0.48 - 0.81 
 




0.39 0.30 - 0.51 
 
 0.43 0.33 - 0.57 
 
Living arrangement (no = reference) 
    
 
   
Spouse/partner 1.48 1.15 – 1.91 0.002  1.40 1.07 - 1.82 0.014 
Education level attained (≤12 years = reference) 
    
 
   
>12 years 
 
2.17 1.76 - 2.70 <0.001  1.93 1.54 - 2.42 <0.001 
Health Authorities  
    
 
   
North (reference) 1 
 





1.10 0.78 - 1.53 
 
 1.07 0.75 - 1.53 
 
South/East 1.22 0.93 - 1.59 
 




2.07 1.47 - 2.90 
 
 1.89 1.32 - 2.71 
 
Smoking status 
    
 
   
Never (reference) 1 
 





0.65 0.51 - 0.83 
 




0.81 0.62 - 1.06 
 
 0.98 0.74 - 1.31 
 
Body mass index (≤25 kg/m2 = reference) 
    
 
   
>25 kg/m2 
 
1.00 0.81 - 1.23 0.997  1.00 0.80 - 1.26 0.997 
Medical history (no = reference) 
  
 
   
Prior MI / CABG  
 
0.49 0.34 - 0.71 <0.001  0.55 0.37 - 0.81 0.002 
Diabetes mellitus 
 
0.73 0.53 - 0.96 0.047  0.85 0.61 - 1.20 0.359 
Prior stroke 
 
0.48 0.24 - 0.96 0.038  0.65 0.31 - 1.35 0.244 
Prior hypertension treatment 
 
0.63 0.52 - 0.76 <0.001  0.69 0.55 - 0.86 0.001 
Prior lipid-lowering treatment 
 
0.71 0.59 - 0.86 <0.001  0.95 0.76 - 1.18 0.624 
PCI indication (Stable AP = reference) 
    
 
   
Acute Coronary Syndrome 
 
1.10 0.89 - 1.37 0.391  1.02 0.79 - 1.30 0.903 
CR participation (no = reference) 
 
1.02 0.83 - 1.24 0.877  1.01 0.82 - 1.25 0.940 
 
a  Due to missing in some of the independent variables, this analysis was restricted to completed case analyses of patients aged 59 years 
and younger at index event (n=2038). 
b “Unemployed” was defined as patients who were unemployed or retired. 
AP: Angina pectoris; CABG: coronary artery bypass graft; CI, confidence interval; CR: cardiac rehabilitation; HT: hypertension; MI: 




Supplementary Appendix Table 1. Baseline characteristics of the propensity-matched cohort (n=1416) 
 Matched cohort Standardised  




Age, Years ± SD 52.3±5.3 52.1 ±5.6  0.037 
Male, n (%) 572 (80.8) 567 (80.1)  0.018 
Living arrangement, n (%)    
Spouse/partner 592 (83.6) 587 (82.9) 0.019 
Educational level attained, n (%)    
≤12 years 442 (62.4) 444 (62.7) -0.006 
>12 years 222 (37.6) 264 (37.3)  0.006 
Smoking status, n (%)    
Never  171 (24.2) 172 (24.3) -0.002  
Former 181 (25.6) 172 (24.3)  0.030 
Current 356 (50.3) 364 (51.4) -0.022 
BMI (kg/m2), mean ±SD 26.7 ±6.9 27.2 ±5.7 -0.079 
Medical history, n (%)    
Diabetes mellitus 69 (9.7) 75 (10.6) -0.030 
Prior MI / CABG surgery 35 (4.9) 33 (4.7) 0.009 
Prior lipid lowering treatment 346 (48.9) 345 (48.7) 0.004 
Prior HT treatment 228 (32.2) 237 (33.5) -0.028 
Indication for PCI, n (%)    
Stable angina 106 (15.0) 114 (16.1) -0.030 
Unstable angina 74 (10.5) 78 (11.0) -0.116 
NSTEMI 245 (34.6) 249 (35.2)  -0.013 
STEMI 283 (40.0) 267 (37.7)  0.047 
Health authority, n (%)    




Central 105 (14.8) 101 (14.3) 0.014 
South/East 395 (55.8) 328 (46.3)  0.191 
West 112 (15.8) 152 (21.5)  -0.047 
SD: standard deviation; BMI: body mass index; CR: cardiac rehabilitation; MI: myocardial infarction; CABG: 
coronary artery bypass graft; HT: hypertension; PCI: percutaneous coronary intervention; NSTEMI: non ST-













(Paper II) Supplementary Appendix Table 1. Baseline characteristics of the entire cohort (n=7068) stratified by subgroups. 
Characteristics Subgroup (n=775) Others (n=6293) P-value 
Age  Years ±SD 64  ±9.2 63  ±10.3 0.004 
Gender– n (%) Male 583 (75.2) 4738 (75.3) 0.965 
Living arrangement – n (%)  Spouse/partner 591 (79.6) 4767 (79.2) 0.774 
Educational level attained – n (%) ≤12 years 495 (66.7) 4188 (69.2) 0.179 
> 12 years 247 (33.3) 1865 (30.8) 
Smoking status – n (%) Never 235 (31.3) 1725 (30.2) <0.001 
Former 319 (42.5) 1963 (34.3) 
Current 196 (26.1) 2030 (35.5) 
BMI (kg/m2)  Mean ±SD / >25kg/m2 529 (68.3) 4121 (65.5) 0.127 
Medical history – n (%) Prior MI 76 (9.8) 588 (9.4) 0.696 
Diabetes mellitus 98 (12.7) 703 (11.2) 0.230 
Prior CABG surgery 58 (7.5) 385 (6.1) 0.136 
Prior stroke 27 (3.5) 233 (3.7) 0.840 
Prior lipid lowering treatment 459 (59.8) 3413 (55.1) 0.14 
Prior HT treatment 321 (41.7) 2682 (42.9) 0.512 
Creatinine concentration (μmol) Mean (IQR) 78.7  ±17.6 78.8  ±25.1 0.893 
Left ventricle ejection fraction – n (%) >40% 282 (95.6) 2337 (92.8) 0.088 
≤40% 13 (4.4) 181 (7.2) 
Indication for PCI – n (%) Stable angina 3307 (39.8) 1817 (29.1) <0.001 
Unstable angina 98 (12.6) 777 (12.4) 
NSTEMI 218 (28.3) 1965 (31.4) 
STEMI 148 (19.2) 1695 (27.1) 
Cardiac rehabilitation Yes 183 (23.6) 1766 (28.1) 0.009 
SD: standard deviation; BMI: body mass index; MI: myocardial infarction; CABG: coronary artery bypass graft; HT: hypertension; IQR: inter quartile range; 
PCI: percutaneous coronary intervention; NSTEMI: non ST-elevation myocardial infarction; STEMI: ST-elevation myocardial infarction   
(Paper II) Supplementary Appendix Table 2. Baseline characteristics of the propensity matched cohort (n=3402) 
Matched cohort Standardised 




Age  Years ±SD 60.3 ±9.4 60.0 ±10.1  0.031 
Gender– n (%) Male 1281 (75.3) 1276 (75.0)  0.007 
Living arrangement – n (%)  Spouse/partner 1272 (78.5) 1227 (75.0)  0.083 
Educational level attained – n (%) ≤12 years 1066 (62.7) 1140 (67.0) -0.090
>12 years 635 (37.3) 561 (33.0) 0.009
Smoking status – n (%) Never  446 (29.1) 444 (29.1) 0 
Former 481 (31.4) 460 (30.2)  0.026 
Current 604 (39.5) 620 (40.7) -0.025
BMI (kg/m2)  Mean ±SD 26.4 ±6.5 26.7 (5.5) -0.050
Medical history – n (%) Prior MI 110 (6.5) 123 (7.2) -0.151
Diabetes mellitus 179 (10.5) 186 (10.9) -0.013
Prior CABG surgery 51 (3.0) 51 (3.0) 0
Prior stroke 48 (2.8) 52 (3.1) -0.066
 
 Prior lipid lowering treatment 841 (49.4) 864 (50.8) -0.028 
 Prior HT treatment 623 (36.6) 639 (37.6) -0.021 
Creatinine concentration (μmol)  Mean ±SD   76.6 ±23.1 76.6 ±21.4 0 
Left ventricular ejection fraction – n (%) >40% 495 (90.5) 503 (91.3) -0.028 
 ≤40% 52 (9.5) 48 (8.7)  0.282 
Indication for PCI – n (%) Stable angina 270 (15.9) 306 (18.0) -0.056 
 Unstable angina 186 (10.9) 210 (12.3) -0.044 
 NSTEMI 589 (34.6) 577 (33.9)  0.015 
 STEMI 656 (38.6) 608 (35.7)  0.060 
Health authority – n (%) North 195 (11.5) 301 (17.7) -0.176 
 Central 280 (16.5) 272 (16.0)  0.014 
 South/East 1000 (58.8) 950 (55.8)  0.061 
 West 226 (13.3) 178 (10.5)  0.087 
SD: standard deviation; BMI: body mass index; MI: myocardial infarction; CABG: coronary artery bypass graft; HT: hypertension; PCI: percutaneous coronary 
intervention; NSTEMI: non ST-elevation myocardial infarction; STEMI: ST-elevation myocardial infarction    

  
 
 
 
 
  
 
